Company name Booth Number Meeting status

Gerresheimer 4157 Requested

George Washington University 4035
Seacross Pharmaceuticals 4049
Propharma Group, Inc 4035
Kindeva Drug Delivery 4421
University of South Florida 3849
Pfizer Inc. 2327 Requested
Emergent 5835
NVIDIA 4217
Battelle 1703
NIH Seed Fund Programs (SBIR/STTR) 825 Requested
Lubrizol Corporation 4717
Jiangsu Hengrui Pharmaceuticals Co., Ltd 4421 Requested
Yifan Pharmaceuticals 3623 Declined
Novavax, Inc 1421
Amgen Business Development 3027 Declined
Syneos (1) 2111 Requested
Avantor Sciences 3027 Requested
Publicis.Sapient 3027
Houlihan Lokey 5607
PPD, part of Thermo Fisher Scientific 4554 Declined
University of California, San Francisco 2625
Jefferson Health 1711
Evonik Corporation 2223
EVERSANA 1917 Requested
MilliporeSigma 4735
Legend Biotech USA, Inc. 4507 Declined
Cencora 4253
The University of Chicago 2119
Cipla Ltd. 4507 Scheduled
University of Louisiana, Lafayette 3917
Regeneron Pharmaceuticals, Inc. 3617 Requested
Mayo Clinic 2415 Requested
Johnson & Johnson 5707 Declined
Merck 5407 Requested
Catalent 5535 Requested
Genescience Pharmaceuticals Co., Ltd 4507
IQVIA 4035 Requested
Cardinal Health Regulatory Sciences 4514
Bausch Health Companies, Inc. 1703 Declined
IMEC 4023
BASF Bioservices 1605 Declined
Best Buy Health 2404
NNIT 1211
Organon & Co. 811 Declined
Amneal Pharmaceuticals, LLC 2223
CTI Clinical Trial and Consulting Services 5407
Merck Animal Health 5407 Requested
ICON Plc. 3424 Declined
Noven Pharmaceuticals, Inc 1421 Declined
City of Phoenix 3617
Stanford Medicine 4217
Ginkgo Bioworks 4035 Declined
ABBVIE, INC. 2611
The Henry M. Jackson Foundation for the Advancement of Military Medicine 1027
AbbVie, Inc. 2611 Declined
Piramal Pharma Solutions 4613
Leo Pharma A/S 4507 Declined
CSPC Pharmaceutical Group Ltd 4335
Gan & Lee Pharmaceuticals 1421 Requested
Bayer 1703 Requested
University of Pittsburgh 4635
Tsumura USA, Inc. 4421
University of Michigan 2211
University of Texas, MD Anderson Cancer Center 3849
EMD Serono, Inc. 2319
Cincinnati Children's Hospital 4507
Qilu Pharmaceutical Co., Ltd. 1421 Requested
Endo 5407
National Jewish Health 903
BioMarin Pharmaceutical, Inc 3935
Eli Lilly and Company 2311 Scheduled
Certara 5001
SRI International 4507
University of Colorado, Anschutz Medical Campus 5707
NOF Corporation 1211
Frederick National Laboratory for Cancer Research 903
Princeton University 4149
Evonik Corp. 2223 Declined
Takeda Pharmaceuticals 2625 Requested
Alexion, AstraZeneca Rare Disease 4235 Requested
Curia 4607
Biocytogen Pharmaceuticals(Beijing)CoLtd 2425 Declined
Insmed, Inc 3623 Declined
Haisco-USA Pharmaceuticals, Inc. 4507
Deutsche Bank 3523
Abbott Labs 2611 Requested
Yale Ventures – BD & Partnering 2425
BRIDGE Innovation & Business Development 4023
Lupin, Inc. 3623 Requested
Elanco 820 Requested
Miltenyi Biomedicine 4735
KOTRA (Korea Trade-Investment Promotion Agency) 5407
Incyte Corporation 5940
NHLBI/NIH Seed Fund Programs (SBIR/STTR) 5015
Sarepta Therapeutics 3843 Requested
Genentech and Roche 5607 Requested
Revvity 5051 Declined
Cytiva 3221 Requested
Celanese 2111
Resilience 5051 Requested
GenScript USA Inc. 2223 Scheduled
Fosun Pharmaceutical USA 2311
Gilead Sciences, Inc 4035 Requested
Teva Pharmaceutical Industries 1711 Requested
Inotiv 2414
SMC Ltd 811
Ecolab Life Sciences, Purolite 4649
Cambrex 4919
PTC Therapeutics, Inc 3027 Declined
Duke University Office for External Partnerships 4807
West Pharmaceutical Services 5017
Viatris 4947 Declined
Sanford Burnham Prebys Medical Discovery Institute 1711
PCI Pharma Services 6050
Exeltis USA 4635
Pfizer CentreOne 3523 Declined
Roswell Park Comprehensive Cancer Center 4745
Amgen 3027
Amgen Biosimilars 3027
Cytiva Technology Acquisition, Licensing & Partnering 3221 Scheduled
Bristol Myers Squibb Business Development 1711 Requested
Boehringer Ingelheim Animal Health 3743
Oregon Health & Science University 1225
GenScript 3823 Requested
RemeGen 3424
Aptar Digital Health 4035
Alnylam Pharmaceuticals, Inc 3424
Nomura Securities International, Inc. 1211
BeiGene, Ltd. 3424 Declined
Mayo Clinic 2415
Evercore Partners 4515
Catalent 5535 Requested
Vetoquinol S.A. 811
Biogen 4049
Zoetis 4023 Declined
 Company status Company type(s)

Medical device or technology

CMO,
BiotechCRO
or pharma, therapeutic R&D
Biotech or pharma, therapeutic R&D
Biotech or pharma, animal health
SPONSOR Financial,
CMO, CRO legal, consulting
ACADEMIC CAMPUS Other R&Dtech
Academic, services
transfer
SPONSOR Biotech
Biotech or pharma, therapeutic
or pharma, therapeutic R&D
R&D
SPONSOR CMO,
BiotechCRO
or pharma, therapeutic R&D
Other R&D services
Medical
Biotech -device
food &oragriculture
technology
Medical device
Public, NPO, or technology
govt., economic development
Biotech
Medical or pharma,
device animal health
or technology
Biotech or pharma, therapeutic R&D
PRESENTING Biotech or pharma, therapeutic R&D
COMPANY
MEMBER Biotech or pharma, therapeutic R&D
SPONSOR Biotech or pharma, therapeutic R&D
SPONSOR Medical device or technology
SPONSOR Other
Biotechproducts or services
or pharma, therapeutic R&D
Biotech - food & agriculture
Diagnostics
Investment bank
Financial,
CMO, CRO legal, consulting
ACADEMIC CAMPUS Digital health
Academic, tech transfer
Institute,
Institute, hospital research
hospital research
Academic,
CMO, CROtech transfer
Biotech or pharma, animal health
Digital health
Other
CMO,products
CRO or services
MEMBER Biotech or pharma,
Biotech or therapeutic R&D
pharma, therapeutic R&D
SPONSOR Other products or services
MEMBER Financial,
Academic,legal, consulting
tech transfer
Institute,
Biotech orhospital
pharma,research
therapeutic R&D
Academic, tech transfer
BIO BOARD CMO,
BiotechCRO
or pharma, therapeutic R&D
Diagnostics
SPONSOR Institute,
Biotech orhospital
pharma,research
therapeutic R&D
SPONSOR Biotech or pharma, therapeutic R&D
CMO, CRO
Biotech or pharma,
Biotech or therapeutic R&D
pharma, therapeutic R&D
CMO, CRO
Digital
Biotechhealth
or pharma, therapeutic R&D
Biotech or pharma,
Biotech or animal health
pharma, therapeutic R&D
Other R&D services
Medical
Other R&D device or technology
services
Biotech
Medical -device
food &oragriculture
technology
Digital health
 Other products or services
SPONSOR Biotech or pharma,
Biotech or therapeutic R&D
pharma, therapeutic R&D
Biotech or pharma, therapeutic R&D
Medical
CMO, CRO device or technology
SPONSOR Other
Biotechproducts or services
or pharma, therapeutic R&D
CMO, CRO
Other
Biotechproducts or services
or pharma, therapeutic R&D
SPONSOR Medical device or technology
ACADEMIC CAMPUS Public,
BiotechNPO, govt., &
- industrial economic development
environmental
BIO BOARD Academic,
Biotech tech transfer
or pharma, therapeutic R&D
Biotech - food & agriculture
Biotech or pharma, therapeutic R&D
CMO, CROtech transfer
Academic,
Institute,
Biotech orhospital
pharma,research
therapeutic R&D
CMO, CRO
Biotech or pharma,
Biotech or therapeutic R&D
pharma, therapeutic R&D
Biotech or pharma, therapeutic R&D
PRESENTING Biotech or pharma, therapeutic R&D
COMPANY
BIO BOARD Biotech or pharma, therapeutic R&D
ACADEMIC CAMPUS Academic, tech transfer
Institute,
Biotech orhospital
pharma,research
therapeutic R&D
ACADEMIC CAMPUS Academic, tech transfer
Biotech orhospital
Institute, pharma,research
therapeutic R&D
Biotech or pharma, therapeutic R&D
Biotech or pharma, therapeutic R&D
Academic, tech transfer
Institute,
Biotech orhospital
pharma,research
animal health
BiotechCRO
CMO, or pharma, therapeutic R&D
Biotech
Academic,or pharma, therapeutic R&D
tech transfer
BIO BOARD Institute,
Biotech orhospital
pharma,research
therapeutic R&D
SPONSOR Biotech or pharma, therapeutic R&D
Biotech
Other or pharma,
R&D servicesanimal health
MEMBER Digital health
Biotech or pharma, therapeutic R&D
Digital health
Academic, tech transfer
Institute, hospital
Synthesis, analytic,research
diagnostic services
Other R&D
Other R&D services
services
Public, NPO,
Academic, govt.,
tech economic development
transfer
Biotech
CMO, CRO or pharma, therapeutic R&D
SPONSOR Biotech or pharma,
Biotech or animal health
pharma, therapeutic R&D
BIO BOARD Biotech or pharma, therapeutic R&D
CMO, CRO
Other R&D
Biotech servicestherapeutic R&D
or pharma,
Biotech or pharma, therapeutic R&D
Biotech or pharma, therapeutic R&D
Investment bank
Biotech or pharma, therapeutic R&D
Academic, tech transfer
Biotech or pharma, animal health
ACADEMIC CAMPUS Institute, hospital research
Biotech or pharma,
Biotech or therapeutic R&D
pharma, therapeutic R&D
PRESENTING Biotech or pharma, animal health
COMPANY Investor (buy-side
Medical device or sell-side research)
or technology
Supplier, engineering
Other products or services
BIO BOARD Public,
BiotechNPO, govt., therapeutic
or pharma, economic development
R&D
Medical device or technology
MEMBER Biotech or pharma,
Biotech or therapeutic R&D
pharma, therapeutic R&D
SPONSOR Biotech or pharma, therapeutic R&D
Biotech or pharma, therapeutic R&D
PRESENTING Diagnostics
Medical device or technology
COMPANY Biotech
Medical or pharma,
device therapeutic R&D
or technology
PRESENTING Supplier,
CMO, CRO engineering
COMPANY Biotech or pharma,
Biotech or therapeutic R&D
pharma, therapeutic R&D
Biotech or pharma, therapeutic R&D
MEMBER Biotech or pharma, therapeutic R&D
Biotech or pharma, therapeutic R&D
Biotech or pharma, therapeutic R&D
Medical
Medical device
device or
or technology
technology
Other R&D services
Other products or services
Biotech
Biotech or
or pharma,
pharma, therapeutic R&D
animal health
MEMBER CMO,
BiotechCRO
or pharma, therapeutic R&D
Institute, hospital research
Other
MedicalR&D services
device or technology
Other
Biotech or pharma,services
products or therapeutic R&D
Public, NPO, govt., economic development
Academic,
CMO, CROtech transfer
Other
Biotechproducts or services
or pharma, animal health
SPONSOR CMO, CRO
MEMBER Biotech or pharma,
Academic, therapeutic R&D
tech transfer
SPONSOR Biotech or pharma, therapeutic R&D
Biotech or pharma, therapeutic R&D
SPONSOR Biotech or pharma, therapeutic R&D
SPONSOR Medical device or technology
SPONSOR Biotech or pharma, therapeutic R&D
PRESENTING Biotech or pharma, animal health
COMPANY Academic, tech transfer
Biotech or pharma,
Biotech or therapeutic R&D
pharma, therapeutic R&D
Biotech or pharma, therapeutic R&D
Other products or services
SPONSOR Digital
Biotechhealth
or pharma, therapeutic R&D
Investment bank
BIO BOARD Biotech or pharma, therapeutic R&D
Diagnostics
Institute,
Investment hospital
bank research
CMO, CRO
Biotech or pharma, therapeutic R&D
 Biotech or pharma, animal health
BIO BOARD Biotech or pharma, therapeutic R&D
PRESENTING Biotech or pharma, animal health
COMPANY Medical device or technology
 Brief description

Gerresheimer is a global solution partner for pharma, biotech

and healthcare. It develops & manufactures primary
packaging for drugs.. Our intelligent drug delivery devices &
Seacross Pharmaceuticals is a global pharmaceuticals
platforms enable reliable administration of active medical
company dedicated
ProPharma Group is on thethe development
leading of generic drugs,
global, independent, single-
innovative
source smallofmolecule
provider regulatory, drugs, and next generation
compliance, clinical of
research,
Market leading CDMO offering drug-device combination
ADC, with
pharmacovigilance, focus on oncology
andinjectable, and immuno-oncology.
medical information services serving
product servicespartners,
USF is seeking across licensees and inhalation,
investors nasal,
for our wide
pharmaceutical,
transdermal and biotechnology,
microneedle and medical
platforms device
including cGMP
ranging portfolio of life science technologies.
analytical services.
We have the scientific and regulatory compliance experience,
end-to-end
World leader development
in artificial and manufacturing
intelligence expertise, and
and supercomputing
efficient
with technologyontransfer
a major capabilities
and life required to bring
Battelle is thefocus healthcare
world's largest, independent, sciences
not for profit
life-saving, life-extending products to market.
R&D organization
The National withof
Institutes billions
Healthin(NIH)'s
managed SmallR&D spending
Business
annually. For over forty years, Battelle
Program, also known as America’s Seed Fund, provides has innovated within
over
the life sciences, medical devices, and
$1.3 billion in funding, making it one of the world’s largest pharmaceutical
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (JHP) is
early-stage capital sources for life sciences.
committed to bringingishigh
Yifan Pharmaceutical quality & affordable
an innovative products to
R&D and production
patients
company by R&D
focusing innovation and
on pharmaceutical collaboration in the areas of
Novavax is a biotechnology company and that health
promotes products
oncology,
including metabolic, autoimmune, respiratory, renal, CV and
improved macromolecules,
health globally through small molecules,
the discovery, synthetic
development
biologics, and special TCM.
and commercialization of innovative vaccines to prevent
Syneos Health® is the only fully integrated
serious infectious diseases.
biopharmaceutical solutions organization built to accelerate
customer success. We translate unique clinical, medical
Publicis Sapient is a digital transformation partner helping
affairs and commercial insights into outcomes to address
establishedLokey
Houlihan organizations
(NYSE: HLI) get toistheir future,
a global digitally-enabled
investment bank
state,expertise
with both in the in way
mergerstheyand work and the way
acquisitions, they serve
capital their
markets,
PPD, part of Thermo Fisher Scientific, provides clinical
customers.
royalty and revenue interest services
monetizations and financings,
development
UCSF is a topand worldanalytical
ranked university that does advanced
board advisory, and financial restructuring.
biomedical research, graduate-level education in the life
sciences and health professions, and excellence in patient
Develops and manufactures complex parenteral drug delivery
care. Innovation Ventures leads commercialization of UCSF
products
EVERSANA® (e.g., long-acting
is the leading injectables,
independent liposomes, LNPs);
global commercial
non-animal
partner to the derived cell culture specialty ingredients (e.g.,
lifeissciences
MilliporeSigma your oneindustry.
trusted partner to support you
dipeptides, amino acids, Phytocol); and precision
across the many steps of the
Legend Biotech is a global biotechnology drug development company & dedicated
manufacturing
to treating, process, while delivering risk-mitigating
We supportand one day
all stages ofcuring,
the product life- threatening
lifecycle to diseases.
maximize
solutions
We are with biosafety
developing advancedtesting celland analytical
therapies development
across a diverse
your product's success
Founded in 1890, UChicago is home to world class research
array of technology platforms.
and
Ciplamedical
is a global center, inc anCompany
pharma NCI designatedwith US$3 cancer center.
bn revenues;
We
with are looking
large US, India, to explore broad
Africa, EU, partnership
AZ, Latam opportunities
businesses
The University of Louisiana, a top-tier research university, is
research and clinical trials and licensing techs.
developing is
Regeneron a bioinnovation district. UL, home
a leading biopharmaceutical to thewith
company Nation's
a
largestarray
wide NHPofCRO, platform has technologies
secured $100M in State investment
genetics, biology and
and
Connecting pharma and biotech to Mayo Clinic Diagnostics.
is seekingbased
biologics P3 partners
medicines for its
. WecGMP apply & these
bioinnovation
platforms across
We
As theoffer a widelargest
world’s range andof laboratory testing,
most broadly-based diagnostic
healthcare
all therapeutic
expertise, areas, resulting inclinical
7 approved products and a
company, we are committed to using our reach support
assay validation, and data to and size for
biological
good. Wediscovery, are blending assayourand AI development,
heart, science, and ingenuityand clinicalto
We are the global leader in enabling pharma, biotechnology,
profoundly change the trajectory of health for humanity.
and consumer health
- A fully-owned partners
subsidiary of to optimize product
Changchun High-Tech
development,
Industry Group launch, and full
(SZ000661, life-cycle
market cap supply
at for patients
202 billion RMB)
Biopharmaceutical Service Provider
around the world.
contributing 80%+ revenue.
Cardinal Health Regulatory Sciences is a team of driven
solutionists
Bausch Health whoCompanies
expertly navigate
Inc. is athe complex
global and evolving
company that
regulatorymanufactures
develops, landscape, accelerating
and markets paths
a to market
range of — and the
Imec is a nanoelectronics R&D center working with partners
critical therapies your patients
pharmaceutical, need.
around the globemedical
BASF Bioservices toprovides
leveragedevice and over-the-counter
advanced
end-to-end silicon (CMOS)to Life
R&D services
products, primarily
technology for life in the therapeutic
sciences and medical areas of eye health,
applications.
Science,
Monitor, Biotechnology,
manage, and communicate and BASF Group with study companies. Our
participants
best-in-class
remotely. R&D platform includes all capabilities required
for biotechnology research services and product
NNIT is a strategic consulting group focused on the life
sciences. is
Organon We supporthealthcare
a global organizations company by ensuring
formed they throughhavea the
proper people,
spin-off has
froma Merckprocesses,
& of Co.,partners,
Inc., and
Rahway, technologies
NJ,products in
USA, (NYSE: place
Amneal portfolio over 225 marketed and
to enable
MRK) successful
knowna as and
MSD outside compliant operations
of thepharmaceutical and
United States and product
also
CTI markets
is a privately portfolio
held, of branded
full-service Global Central products
Canada, its
through to focus
Specialtyon improving
segment the health
focused of women
principally on central
Laboratory
Merck Animal Health is a global leader in the research,
nervous system and endocrine disorders. For more info visit
development,
ICON plc is a manufacturing
global providerand sale ofMedical
of CRO, veterinary Device and
medicines.
In-vitro
Noven Pharmaceuticals is a specialty pharmaceuticaland
Diagnostic clinical and regulatory solutions
services. engaged in the sale of prescription products.
company
Ranked #1 in Life Science Job Growth in Emerging Life
Specific
Science focus in ADHD, digital setting
therapythe andstandard
transdermal
StanfordMarkets.
MedicineInnovators
is leading are the biomedical revolution in in
drug delivery.
precision medicineAs well
& as
driving specialty, small
translational volume
discovery nichein
precision
A synthetic health
biology by leveraging
platform company our iconic place inwith
working Silicon
partners
Phoenix where
Valleydiscovery Ideas
and the university’s are nurtured,
innovation innovation is
and excellence celebrated,
across
from
AbbVie is a global, research-based biopharmaceuticalup. We
projects through manufacturing scale
disciplines.
collaborate with companies across innovative
various modalities
company committed
HJF is a global to delivering
nonprofit created by Congressmedicinesto accelerate and
including
having a small molecules,
remarkable impact biologics,
on people’s vaccines,
lives. and cell/gene
AbbVie
progress
AbbVie isinamilitary medicine.
global, research-based biopharmaceutical
Contract Manufacturing has been serving our partners for
company
Global CDMOcommitted to delivering
offering end-to-endinnovative development medicines
and
which have a remarkable
manufacturing solutions impactthe
across ondrug
people’s life lives across
cycle. We serve
Global specialty pharma company focusing on medical
core therapeutic
our customersWe areas, including
through aa globally immunology,
integrated oncology,
network of
dermatology.
CSPC is one of thehave leading mission
innovative to help people
pharmaceutical achieve
facilitiesskin.
healthy in North America, Europe, and Asia.
companies
Gan&Lee isinaChina with fully
China-based integrated capabilities
pharmaceutical company of
R&D, manufacturing,
specializing in the and
development, commercialization. The company
Bayer is a Life Science companyproduction,with a moreand than 150-year
was founded
commercialization in 1938 and its
of recombinant HQ in Shanghai,
insulin also
analogs listed
and otheron
history andamong
Pitt ranks core competencies
the top universities in the areas
in the of health
world forcare and
innovative
agriculture.treatments
With our With for diabetesproducts,
innovative and obesity.are
biomedical
Tsumura USA, research.
Inc. is a 100% $1.2 bn inofwe
oversubsidiary annual research
a Japan-based
contributing
funding Pitt toafinding
is solutions tofor
partner-of-choice some of the major
hundreds of companies
pharmaceutical
The University of company,
Michigan Tsumura
(U-M) is & the
Co.,top andpublic
is engaged in
annually
clinical seeking
development to advance
of a their
pharmaceutical basic & translational
botanical drug, TU-
universityIndustry
Strategic in research spending
Ventures in the United
is responsible for States
connectingwith MD
100,
morewhich has been
than Cancer
$1.9 billionapproved
in toannual and marketed
spending, in Japan as a
Anderson Center industry for thewith $800ofmillion
purpose
focused
generatingon translational
medical research. partnerships that bring new drugs,
Cincinnati Children's is seeking partnerships with industry
diagnostics, devices and imaging agents to the market for the
and
Qiluventure
Pharmagroups is a topto10 accelerate
pharma in theChina.
development
We cover anddiverse
commercialization
therapeutics of
areas, with our research
focuses discoveries.
on co.
oncology, With 1,000+
cardiovascular,
Endo is a diversified spec. pharma that develops &
faculty, we
cerebrovascular,have a robust
and pipeline and portfolio of
markets
Nationalbranded
Jewish Healthspec.CNS pharma diseases.
products, branded
is a world-renowned & Gx
respiratory,
sterile injectable
medical (SI) products &inGx pharmaColorado.products.
BioMarinand research
develops institution
and commercializes Denver, innovative We
collaborate with
biopharmaceuticals pharmaceutical,
for rare and biotechnology,
serious diseases diagnostic &
At Lilly, we unite caring with discovery to createand medical
medicines
medical
conditions.device companies worldwide to develop therapeutic
that makethelife
Certara, better Model
premier for people InformedaroundDrug the world.
DevelopmentWe do this
by putting the We
organization. morecombine
than 45substantial
million people that depend
development & onout
SRI is an independent, nonprofit research center founded
our medicines
commercial at the
expertise center
with Our of everything
leading data science we do. &novel
of
TheStanford
University Univ. of in 1946.
Colorado pipeline
Anschutz includes
Medical Campus
technology,
platforms fortointracellular
integrate virtual delivery trials,
of simulation,
wide variety market
of cargos,
serves as the premiere healthcare
NOF CORPORATION is the leading and commercial
biomedical research supplier of
etc. We
center are seeking
in the Rocky commercial
Mountain partners
region. for out-licensing.
DrugFrederick
The Delivery (DDS)
National products
Laboratory and is customized
dedicated services
to improving for
all yourhealth
human drug delivery
through development
discovery and and formulation
innovation in needs.
the
Princeton University is a private Ivy League research
biomedicalinsciences,
university focusing on cancer, AIDS, and
Develops andPrinceton,
manufactures NewcomplexJersey. parenteral drug delivery
emerging infectious diseases.
products (e.g., long-acting injectables,
Takeda is a patient-focused, innovation-driven liposomes, LNPs);
global
non-animal
pharmaceutical derivedcompanycell culture
that specialty
builds on ingredients
a distinguished (e.g.,
Alexion, AstraZeneca Rare Disease, is the group within238-
dipeptides, amino
year history, aspiring acids, Phytocol);
to bring and
better health precision
andfollowing
a brighterthe
AstraZeneca
Curia is a Contractfocused on rare diseases,
Development created
and Manufacturing
future for people
2021 acquisition worldwide.
Organization withofover
Biocytogen Pharmaceuticals
Alexion30 years Pharmaceuticals,
of experience.
(Beijing) Co., Ltd.Our
Inc. biologics
is a global
offering
biotech spans
company discovery
that drives to clinic
the and
research fill-finish
and services of
development
Well-capitalized biotechnology company focused on rare and
across
new monoclonal
drugs antibodies,
with innovative recombinant
technologies. Noproteins and
service-provider
pulmonary
Haisco is a diseases
publicly traded specialized pharmaceutical group
meeting schedule at BIO,
that combines
Leading globalnew bankmedicine
providing research and development
a full range of financial with
manufacturing
products and sales. Haisco focus on CNS/Pain,
Abbott isand services.
a global companyHealthcarein branded investment banking team
pharmaceuticals,
Pulmonary/Respiratory,
of 60+ professionals with Oncology
deep and Metabolic
expertise Disease.
diagnostics,
Yale Ventures: medical
helpingdevices
develop nutrition. thatbiopharma,
andinnovations across
impact the
services and HealthTech; active in M&A, equity and debt
world's greatest challenges.
BRIDGE Innovation & Business Development seeks partners
to further
Lupin is the develop novel assets
11th largest genericand platforms
company in RNA/siRNA,
in the world and
gene therapy,
3rd largest novel
pharma editing
company approaches,
in ELAN)
the US by oncology,
Elanco Animal Health (NYSE: is aprescriptions.
global leader in
immunology
Lupin develops andandneurotherapeutics
commercializes developed
branded, at UMass
generic and
animal health dedicated to innovating
Miltenyi Biotec is a global provider of products and services and delivering
biosimilarand
products products
services and to also has and
prevent a strong
treat biologic
disease and
in small
farm
that
Come advance
visit booth biomedical
#5407 to research
meet 26 to Korean
clinicalcompanies
applications, with
animals
including and pets,
CDMO servicescreating value
from for farmers,
Miltenyi Bioindustry pet owners,
notableisinnovations
Incyte via BIO
a global biopharmaceutical One-on-One company Partnering™.
that is focused
on finding Innovation
BioHealth solutions foris serious unmet medicalintermediary
a commercialization needs through in
the discovery,
Maryland. With development
a unique EIR and commercialization
program we both of novel
co-found
Sarepta is a global biotechnology company on an urgent
medicines.
bio- and med tech companies, investing our resources in
mission:
Roche is to engineer
a global precision
pioneer genetic medicine
in pharmaceuticals andfor rare
diagnostics
venture
diseases formation, advise
that devastatescience client
lives and companies, short. lives. the
and support
focused on
Revvity is aadvancing to cut
life sciences and diagnostics
futures
improve people’s
company As
an integral member
committed to acceleratingof the Roche Group and
the translation founder of
of genomic the
insights
biotech industry,
into advanced Genentech
therapies. Ourbrings
cell and transformative
gene therapymedicines portfolio
Celanese creates innovative sustained-release parenteral
spans multiomic discovery tools, payload and delivery and
dosage
Resilienceforms is afor small molecules,technology
biomanufacturing peptides, biologics
companyand
RNA. With
seeking to has our
invest drug delivery technology and IP portfolio,
GenScript an in R&D, work
established directly
global with across
presence innovators Greater
we strive to
(transaction-type positively
agnostic),impact therapeutic
and andapply data outcomes
science towith drive
China, North America, the EU,
A global innovation-driven pharmaceutical and healthcare Asia Pacific.
improvements to all elements of biomanufacturing.
industry group. Fosun
Gilead Sciences, Inc. isPharma directly operates
a research-based businesses
biopharmaceutical
including
company pharmaceuticals,
that discovers, medical
develops devices,
and(NYSE medical
commercializes
Teva Pharmaceutical Industries Ltd. and TASE:
diagnosis,
innovative and healthcare
medicines in services.
areas of unmet medical need. to
TEVA)ishas
Inotiv your been developing
dedicated and producing
discovery-through-approval medicines partner.
improve
Our people’s
innovative lives fordeliver
scientists more than seamlessa century. We areofa
integration
With 35 years of experience, SMC Ltd. offers "end-to-end"
global
research leader
models, in generic and specialty
multi-platform medicines
technologies, and. discovery
services
Purolite andfor drug
Ecolab delivery devices,
Life Sciences combination
provide products,
comprehensive and
expertise across therapeutic
clinical/commercial areas & Our
manufacturing. modalities
cGMP to maximize
sites provide
solutions
Cambrex and is thetechnical expertisecompany
small molecule focused that on downstream
provides drug
device development,
processing, chromatography technology platforms,
solutions, Aseptic
cleaning, fill
sanitization
substance,
PTC drug product
Therapeutics, and analytical
Inc. (PTC) is a global services across
biopharmaceutical the
and contamination
entire drugfocused
lifecycle. control.
Enjoy workingdevelopment
with our experts to
company on the discovery,
Office for External Partnerships establishes purposeful and
accelerate your small
commercialization of tomolecule
novel andand rareBiopharmaceutical
disease medicines.
external
West works partnerships
with Pharma/Biotech support research
partnersfrom all disciplines,
to help package
accelerate
and deliver basic and
injectable translational
drugs, by research,
providing drive innovation
comprehensive
Viatris is a unique global healthcare company focused on a
across
solutionsDuke, and address
including packaging your components,
organization’s drugmost delivery
wide variety
Sanford Burnham of therapeutic
Prebys isareas. dedicated to discovering the
devices and contract services
fundamental
We provide clinical molecular andcauses
commercialof disease and devising
manufacturing andthe
innovative solutions
packaging therapies to of clients
tomorrow. in the shared goal of Health
Branded Specialty Pharma operating in the Women's
improving
market. patients' lives.
Looking forisacquisition Our dedicated
opportunities,team of experts will
licensing’s
Pfizer CentreOne® a global CDMO embedded within or
support and
partnerships. guide you through the supply chain ecosystem
Pfizer andto
Welcome a leading
Roswellsupplier of specialty APIs.
Park Comprehensive Cancer Backed
Center, by
Pfizer resources,
America's we deliver
first cancer centertechnical
founded in expertise,
1898 byglobal Dr. Roswell
regulatory
Park. support and long-term supply.
Amgen Biosimilars is committed to leveraging its extensive
biotechnology
Formerly GE Healthcare experienceLife to create
Sciences high-quality biosimilars
and reliably supply them to patients suffering from serious
Bristol Myers Squibb is a global biopharmaceutical company
illnesses worldwide.
whose
In 2017, mission
Boehringer is to discover,
Ingelheimdevelop Animaland deliver
Health (BIAH)innovative
joined
medicines
forces with that
Merialhelptopatients
form theprevail
second over serious
largest globaldiseases.
animal
OHSU Innovates advances healthcare technologies,
For more
health information
company with $596Mabout
all of theBristol Myers Squibb , visit
to us at
stemming
GenScript from over
is a global technology in capabilities
research
company
required
awards
with annually,
antibody
maximize
through the
licensing value of
andcell your animal
partnering health
opportunities asset.
discovery,
RemeGen gene
is and
a public therapy platforms.
commercial-stage Wetoare
innovative
improve
looking
biotech
patient lives and
for strategic partners benefit society.
in cell therapy and therapeutic antibody
headquartered
Aptar Pharma is a leading provider of innovative drugWe are
in China with R&D facilities in U.S.
manufacturing
commitedsystems areas.
to the discovery, development and healthcare and
delivery to pharmaceutical,
Alnylam is a biopharmaceutical companyconsumer developing novel
commercialization
biotech customers of biologicsenabling
worldwide, with focused safe, areas in
convenient and
therapeutics
Nomura is a global financial services group RNAi.
based on RNA interference, or with an
compliant medication delivery.
integratedisnetwork
BeiGene a globally spanning
focusedover 30 countries. We
biopharmaceutical provide a
company
variety of to
dedicated advisory
becoming and acapital-raising
leader in the solutions and
discovery to
Connecting pharma and biotech to Mayo Clinic Diagnostics.
companies,
development private equity, governments
of innovative, molecularly and public-sector
targeted and
We offer a wide
Established range
in 1995, of laboratory
Evercore (NYSE: testing,
EVR)diagnostic
is a leading
immuno-oncology
expertise, assay drugs forand
validation, theclinical
treatment dataofto cancer.
support
global
We areindependent
the global leader investment banking
in enabling advisory
pharma, firm.
biotechnology,
biological discovery, assay and AI development, and clinical
and consumer health partners to optimize product
development, launch, and full life-cycle supply for patients
around the world.
Vetoquinol is a top 10 animal health company focused on
small
At animal
Biogen, ourand livestock
mission products.
is clear: we areVetoquinol
pioneers inSA is
interested in
neuroscience. licensing opportunities for management of
Zoetis is a world leader in discovering, developing,
infectious diseases, osteoarthritis, dermatology, parasites ,
manufacturing, and marketing veterinary medicines,
vaccines and diagnostic products, which are complemented
by biodevices, genetic tests and and precision livestock
 Description

Gerresheimer is the global partner for pharmaceutics,

biotech, healthcare, and cosmetics with a very broad product
range for pharmaceutical and cosmetic packaging solutions
Seacross Pharma is a subsidiary of Huiyu Pharmaceuticals
and drug delivery systems. The company is an innovative
Co, Ltd.
From thatconcept
early is a publiclydevelopmentlisted company
through in eachShanghai
clinicalstockphase,
exchange.
product launch,Seacross
and Pharma is a pharmaceutical
commercialization, we partner corporation
with
Kindeva Drug Delivery is a global contract development and
with a strong focus
pharmaceutical, on deliveringand
biotechnology, efficient
medical and advanced
device clients to
manufacturing
USF is a member (CDMO) focused on Association
of the prestigious drug-development of American
tackle complex
combination challenges.
products. Kindeva develops and manufactures
Universities
We’re in relentless (AAU)pursuit and is of a Preeminent
breakthroughs State Research
that change
products
University. acrossUSF a broad
Technology range of drug-delivery
Transfer Office formats, a
envisions
patients’
We are the lives. We innovate
contract development everyand daymanufacturing
to make the world a
division
future
healthier where
place. everyIt wastechnology is given vision
Charles Pfizer’s the opportunity
at the has the to
of Emergent BioSolutions(NYSE:
https://www.nvidia.com/ EBS). Emergent
beginning
scientific and andregulatory
it holds true today. experience,
compliance
Battelle is a global R&D organization that works with
development and manufacturing resources, and efficient
innovative
America’s Seed pharmaceutical,
Fund, powered biotechnology,
by NIH through medical the device,
Small
and diagnostics
Business Innovation organizations
Research to bring
(SBIR) and new innovations
Small Business and
The Lubrizol Corporation, a Berkshire Hathaway company,
solutions
Technology to commercial
Transfer (STTR)markets around
awards, the
partners world.
each year with
is
JHP a market-driven
is a public listed globalglobal company.
biopharma, We combine
headquartered complex in
hundreds of
specialty chemicals companies and
to optimize related stakeholders
the quality, to
performance bring and
Shanghai, China. Founded in 1970,
Yifan Pharmaceutical is an innovative R&D and production it is one of the most
value of our&customers'
innovative inventive products
global while reducing
biopharma companies.their JHP
company
Novavax is focusing
a biotech on company
the pharmaceutical
that promotes and improved
health sectors.
has
Our 15 newismolecular
vision to develop entities approved
innovative drugs inwith
China as well as
definite
global health
Amgen through to
is committed thepartnering
discovery,with development,
innovators and in the
clinical values, to help
commercialization disease-afflicted
ofillness.
innovative vaccines patients
to preventregain serious
fight against serious
Syneos Health® is a leading fully integrated Amgen’s business development
infectious diseases.
team brings together Our proprietary
deep scientific, recombinant
financial, technology
biopharmaceutical
Avantor®, a Fortune solutions
500 company, organization built deal,
is a leading toglobal
accelerate
partnership,
customer and integration
success. We translate expertise—along
unique clinical, with an ability
medical
provider of mission-critical
Publicis Sapient products and services
is a digital transformation partnertohelping
affairs
customers and commercial
inorganizations
the biopharma, insights into outcomes to address
establishedLokey
Houlihan get healthcare,
is an international to theirinvestment education
future, &
digitally-enabled
bank with
government, and
state, bothininmergers advanced
the way theyacquisitions, technologies &
work and the way they serveapplied materials
their
expertise
PPD, part of Thermoand Fisher Scientific, provides clinical
customers. We help unlock value through a start-up mindset
development
Innovation Ventures and analytical services that
Entrepreneurship enable customers
Program. Stephanieto
accelerate
Marrus, innovation and increase drug development
Thomas MBA Jefferson MA,University
ManagingHospitals Director and Entrepreneurship
Thomas
productivity. Utilizing patient-centered strategies and data
Jeffersonhas
Evonik, University
proprietary are parenteral,
partners in drug providing
deliveryexcellent
clinical and compassionate
technologies and facilities care
to for our
develop andpatients in the long-
manufacture
EVERSANA is a 7,500-person private-equity backed global
Philadelphia region,
acting parenterals for educating
its clients Life the health professionals
a wide-range products.of drug- The of
commercialization
MilliporeSigma, theplatform U.S. andfor CanadaScience Life Science business
delivery technologies
company’s integrated such as injectable
partnership solutions microparticles,
are rooted
of MerckBiotech
Legend KGaA, isDarmstadt,
a global leader Germany,in cellleverages
therapy, drivenover in the
35by a
patient
years experience
of for
CDMO and
experience span all stages
and 75toyears of the product life
passion
Cencora haspatients.
a provenWe continue
history buildofour
of collaborative
contract
pipeline
partnership,
testing
of cell
services to redefinewhich
therapy platforms, the industry
includes CDMO
CAR-T, model
CAR-NK,for today’sCAR-
bringing
The Universitycomplex of and
Chicago transformative
brings together therapies to market.
the power of 140
γδ T and
From clinical non-gene-editing
to commercial CARand every point between, we to
technologies. In addition
institutes
Cipla US and revenuescenters have including
crossedan$ NCI-designated
900 m and is fastest
strive for accelerated
Comprehensive Cancer speed
Center,to market and better
a Microbiome outcomes.
focused
growing company among its peers.
Bioinnovation District - New Iberia, La to Lafayette, LA -
center, two U.S. Department of Energy National Labs
home to New Iberia Research Center (NIRC), the Nation's
largest NHP CRO, $100M State investment into BSL-3 Lab,
Inspired by Mayo Clinic’s history of collaboration, we work
cGMP facility and bioinnovation center/incubator. Seeking
to support
Johnson &research
Johnson and (J&J) development
focuses on teams withinall
accelerating thestages
pharmaceutical,
of innovation biotech, and in vitro diagnostics
worldwide and forming collaborations between industries
A Legacy of Innovation
and their collaborators,
entrepreneurs and J&J’s such
global as healthcare
CROs. Thisbusinesses.
includes J&J
Merck has
Catalent a strong
Biologics’ history
drug substanceof success in translating
development andcutting-
provides
edge research scientists,
into entrepreneurs,
life-saving medical and breakthroughs.
emerging companies Our
manufacturing services
2023 Sales: 10.7 Billion RMB leverage advanced technology and
scientific advances have made a difference in the lives of
-proven
IQVIA
expertisebiopharma
Top domestic
(NYSE:IQV)
to help clients company
is a leading
meet and
global
theirleadbiologics
provider player drug
in
of advanced
millions of
substance needs. patients Our worldwide.
development From Merck’s development
teams collaborate closely
endocrinology
analytics, and
technology children’s
solutions, health
and clinical research
Cardinal Health Regulatory Sciences will partner withservices
you to
to the life sciences industry. IQVIA
develop the best regulatory pathway for your product, creates intelligent
connections
through every across
stageall of aspects of healthcare
its lifecycle. throughstrategies
Our regulatory its
Imec leverages its expertise in chip design and technology to
can reduce the risk of failure, and increase your speed to
develop innovativeprovides
BASF Bioservices tools for end-to-end
the life sciences, pharma R&D,
R&D services to Life
clinical
Science, diagnostics,
Biotechnology, therapeutic
and BASF and surgery,
Group biopharma
companies. Our
Best Buy Health partners with pharmaceutical organizations
production
best-in-class andR&D analytical
platform biochemistry
includes all industries.
capabilities required
to enable safe, high-quality, effective remote patient
for biotechnology
monitoring and care research
delivery services
at home. andThrough
product its Current
Health solution, Best Buy Health provides an enterprise care-
https://www.organon.com/organon-business-development/
Amneal Pharmaceuticals, Inc. (NYSE: AMRX)
headquartered
CTI is a GlobalinCentral Bridgewater, Laboratory. NJ, is Our a fully integrated
mission is to raise
pharmaceutical
the expectations company
CROs and focused
Biotech on the
companiesdevelopment,have foranda
At Merck, known as MSD outside of the United States
manufacturing
global laboratory andprovider
distribution by of generic
providing and specialty
industry leading drug
Canada,
Since ourwe are unified
foundation in around
Dublin,our purpose:
Ireland in 1990,We use our themission
customer
power of toservice, consultative
leading-edge science biomarker
to save andthe and laboratory
improve lives of
has been help our clients to accelerate
Asset Acquisition Focused! Small volume to mid sized, late development
around
drugs and thedevices
and world. For that more than aand
save lives century,
improve we’ve beenofatlife.
quality the
stage
Phoenix, Arizonacommercial is theassets targeted.
5th largest city in the nation, the
We are a global provider of consulting, and outsourced
fastest
We aregrowing
definingfor andthe last decade,
developing theranked 5th in the of
next generation Nation
care
as an Emerging
that is proactive, Life Science
predictive Market
andtoprecise, and in 2021
achieving the ranked 1st
Ginkgo is building a platform enable customers to best
in Life
imaginable Science health Job Growth
outcome and
forcan now
every top growth
individual. rate of
program cells
Vision. Expertise. as easilySuccess. as we program computers. The
company's platform is enabling biotechnology applications
The Henry M. Jackson Foundation for the Advancement of
across diverse markets, from food and agriculture to
Military
AbbVie is Medicine,
a global, Inc. (HJF)and
research is adevelopment-based
global, nonprofit
organization
biopharmaceutical authorized company by the U.S.
committed Congress to advance
to discovering and
Piramal Pharma Solutions (PPS) is a Contract Development
military
developing health, which
innovative focuses on
medicines (that the challenges
solve offering
serious faced by
health
and Manufacturing Organization
LEO PHARMA is an independent, innovation-based CDMO) end-to-
issues
end today andcompany address the medical challenges of tomorrow.
pharmaceutical
KEY ASSETS AVAILABLE foundedFORinPARTNERING:
1908 and headquartered
in Denmark.
-Founded
EGFR-ADC We are
(TOPO1) committed to making a fundamental
in 1998, Gan &- Lee Phase 1
Pharmaceuticals (603087.SH),
difference for those who need us most in medical
is a leading
Bayer pharmaceutical
is a global enterprise company with core in China, specializing
competencies in the
in the
life development,
science fields of production,
health care and nutrition.
and commercialization Its products of
The University of Pittsburgh (Pitt) is a top-tier research
insulin analogs
and services and
are designed other innovative
to benefit treatments
people for
by supporting diabetes
institution
Tsumura USA, known Inc. forisits strength
a 100% in the
subsidiary lifeofsciences.
a Japan-based Pitt
effortsinside
ranks to overcome
the top the in
ten majortotal challenges
funding frompresented
the by a
National
pharmaceutical
• The U-M Medical company, Tsumura
School & Co. Tsumura
consistently ranks among U.S.
Institutes
manufactures of Health
and (NIH),
sells more with
than research
120 awards of $675
pharmaceutical
NewsAnderson
MD & Worldhas Report's top medical
4 objectives at BIOresearch
2024: schools and is
botanical
an NIH drugs that
Clinical have
andInvestments: been marketed
Translational Research in Japan
Science as high-
Award
1.
WeFOCUS FUND
are the healthcare business inSearchingthe U.S.A. for&assets
Canada in Phase
for
institution
1 setting with more
for investments than 1,500 active clinical trials.
Merck KGaA, Darmstadt, Germany,
Cincinnati Children's is ranked #1 among pediatric health a vibrant science and
technology
systems andcompany.
researchwas Science is atinthe
institutions heart of With everything we
Qilu Pharmaceutical establishedthe in nation.
1958, and is now 1,000+ one
do. It
faculty drives the
and $695M+ discoveries we make and the technologies
of the isworld’s
Endo leadingresearch
a diversified vertically
specialty
expenditures, the output of our
integrated pharmaceutical
pharmaceutical company
research engine
companies based is a robust
in China pipeline
that develops, and portfolio
manufactures of and
committed to helping everyone
National Jewish Health (NJH), in Denver, Colorado, we serve live their best
is alife
distributes both
through the delivery Finished Formulations
of quality, life-enhancingand Activetherapies. Our
world-renowned
Since our founding respiratory,
in 1997, we medical and research
have applied institution
our scientific
proven
with a success comes
125-year heritage fromof passionate
making team members around
groundbreaking
expertise in understanding
Lilly is a medicine company theturning
underlying science causes
into of genetic
healing to
discoveries
conditions toand providing
create revolutionary
transformative medicines, treatments.using a
make life
Since 2019, better
Certarafor people
has supportedaround the our world.
clients We've as theybeen have
number
pioneering of treatment modalities.
raised morelife-changing
SRI Biosciences than is $65 billion
looking
discoveries
toinmeet
funding for nearly
withfrom
150 years,
venture
commercial capital
partners
and today
and M&A in our
deals.medicines
Furthermore, help more than 51 million
we have delivered more than people
interested
CU Innovations the believes
following areas:
that world-class science should
250 regulatory submissions in the past 4 years.
create world-class impact.
NOF CORPORATION is theEvery day, commercial
leading we bring together supplier of
industry
drugFrederickpartners,
delivery products entrepreneurs, and investors
PEGs,tolipids help andour
The Nationalsuch as activated
Laboratory is a Federally Funded
researchers and
ultrapure Polysorbate healthcare 80. Our providers
cutting solve important
edge products include
Research
Princeton and Development
University is a privateCenter Ivy(FFRDC)
League research sponsored by
Pendant
the National type single
Cancer molecule
Institute (NCI) and currently operatedSS-
PEG linkers for ADCs and by
university
Evonik, hasinproprietary
Princeton, New Jersey.
parenteral, drug delivery
Leidos Biomedical Research, Inc.
technologies
Takeda Pharmaceutical and facilities to develop
Company Limitedand manufacture
is a global, long-
acting
research parenterals for
andindevelopment-driven its clients a wide-range
pharmaceutical of drug-
As a leader rare diseases for more than 30 years,company Alexion
delivery
committed technologies
to serving
bringingpatientssuch as
better healthinjectable microparticles,
and a brighter future to
is
Curia is a Contract Development and Manufacturingby rare
focused on and families affected
patients by translating
diseases and devastating science
conditionsinto life-changing
through thewith medicines.
discovery,
Organization
A clinical-stage with over 30
Biotech years of experience
committed to becoming a global an
development
integrated and commercialization
network of global sites and ofemployees
life-changing partnering
headstream
Insmed Incorporatedof new antibody is a global drugs with proprietary company
biopharmaceutical fully
with
human customers
antibody todiscovery
make treatments broadly accessible
RenMice™ platforms. to
focusedPharmaceutical
Haisco on the unmet needs Group of Co.,
patients
Ltd is with rare diseases.
a pharmaceutical
Biocytogen
The Company's has launched
leadtoproduct Project Integrum,
candidate the
is ARIKAYCE, FDA,
company
With operationsdedicated in overR&D, manufacturing,
70 countries, we encourage our
EMA, and
commercializationPMDA approved
of innovative for treatment
and affordable of refractory
medicines NTM in
people
Abbott to is think
a global forhealthcare
themselves and
leader reward
that helps integrity.
peopleOur live
the disease
large but areas of
focused CNS, oncology,
footprint gives us a respiratory
strong and in
position
more
AboutfullyYaleatVentures
all stages of life. Our portfolio of life-changing
Europe plus aspans
technologies significant presence
the spectrum ofinhealthcare,
the Americas withand Asia
leading
businesses and products in diagnostics, medical devices,
The BRIDGE Innovation & Business Development Office
(BIBD)isleads
Lupin commercialization
an innovation-led activities
transnational at the University
pharmaceutical
of Massachusetts
company headquartered Chan Medical School. We have
withco-
Leveraging each other’s in Mumbai,
strengths to India,
achieve andmore bya global
founded multiple
presence.together successful companies
We develop and commercialize a wide range of – Atalanta
working
Miltenyi Bioindustry, a division of Miltenyi Biotec, is an
branded and generic formulations, biotechnology products
industry-leading
[KOTRA New York CDMO Office]capable of process development and
manufacturing
Of the2002127 offices from early
worldwide, phase through
thecommitted
New York commercial for both
Since Incyte has remained tooffice serves
the relentless as
LVV and
the North cell-based
American therapies.
headquarters, offering comprehensive
pursuit of science that can improve
Bio & Med tech venture formation, NHLBI nondilutive and the lives of patients,
services to U.S. companies
make a difference in healthcare interested
and build in conducting
sustainablebusinessvalue
commercial
We’re ushering ventures
in a new era of drug development with the
with South Korea.
for our stakeholders.
goal of driving
Genentech, efficiencies,
a member of theincluding
Roche Group, shortening
discovers,the time
from lab to patient
develops,ismanufactures, and building the
and commercializes world’s largest
medicines geneto
Revvity committed to partnering to accelerate the progress
therapy
treat manufacturing
patients with from
serious capacity. We’re
and life-threatening collaborating
medical with
of
Withnovel therapies
a rich heritage datingdiscovery to the clinic;
back hundreds to improve
of years, Cytiva
conditions.
human ahealth We are a leading biotechinsights
company, intowith ~40
brings wealthbyofDrug
Our VitalDose®
turning
technical biological
Delivery expertise
Platform and istalent, action.
a broad and
a patented
deep portfolio, and
technology exceptional service help researchers and
Resilience'sthat addresses
mission is to aincrease
variety of formulation
national resilience challenges
in the
biopharma
to achieve advance
the desired therapeutics
release at
profile every stage
for your from
drug.toThe
face
Foundedof pandemic
in 2002 and challenge
listed on and to Hong
the improve Kong access
Stock
VitalDose® Platform
curative, regenerative has been
and preventativeapproved for use inResilience
therapies.global numerous
Exchange in 2015, GenScript has
Founded in 1994, Shanghai Fosun Pharmaceutical (Group) an established
is interested
presence in collaborating with, serving, or starting
Co., Ltd.*across
We strive ("Fosun
to
Greater
transform Pharma"; China, North
stock
and simplify
America,
code: 600196.
care for
theSH,
people
EU,02196.
and
with life-
Asia is
HK) Pacific.
a global Today, over 300,000 pharmaceutical
innovation-driven customers fromand over 160
threatening
Teva Pharmaceuticalillnesses aroundIndustries the Ltd.
world. Gilead's
(NYSE andportfolio
TASE: of
healthcare
products andindustry
pipeline group.
of Fosun Pharmadrugs
investigational directly operates
includes
TEVA)
At Inotiv, haswebeen developing
provide clients and access producing medicines to and
to a fully-assembled
treatments
improve people’s for HIV/AIDS,
lives for hepatitis,
more thancancer,
a century.and We are a
operational drug discovery unit, offering a comprehensive
global leader inapproach
and innovative generic and specialty
to the medicinescontinuum.
entire discovery with a
As a trusted partner in Pharmaceutical, Biologics, and
Personal
With overCare Manufacturing,
40 years’ experiencePurolite and Ecolab
and a growing teamLife of over
Sciences
2,000isexpertsprovide comprehensive
servicing global solutions and
clients from sitescompany technical
in North
PTC a science-led global biopharmaceutical
expertise
Americaon focused
and on downstream is processing,
focused
- DISCOVER theEurope,
discovery,
DUKE'S
Cambrexdevelopment
OFFICE
tried andand trusted in branded
FOR EXTERNAL
and generic markets for API
commercialization of clinically-differentiated and dosage form medicines
development that
PARTNERSHIPS:
If you have an injectable drug, West can help determine the
provide benefits to patients with rare disorders. Founded over
most appropriate
We champion drugaccess.
patient delivery Ourtechnology,
global scale based
andon
patient/user
differentiated needs,
portfolioand the nature
include of the drug
brands, generics, and
Sanford Burnham Prebys is a preeminent, nonprofit
complex medicines
biomedical research across
institute a wide variety
dedicated to of therapeutic
understanding
PCI is as a leading global CDMO, truly spanning the cycle,
areas.
basic humandevelopment
biology and disease and advancing scientific
connecting
Manufacture and marketsand commercialization,
branded prescrition products de-riskingin
discoveries
the supply to profoundly
chain providing impact
clients human
with health. Our
integrated track
end-to-end
Women's Health
Pfizer CentreOne® is a global CDMO embedded within
drug development, manufacturing and packaging capabilities
Pfizer and
Roswell Parka leading
is the onlysupplierupstateof specialty
New York APIs. Ourto
facility global
hold
manufacturing
the National network
Cancer includes
Institute more than
designation of 35 sites across six
"comprehensive
Amgen is committed to partnering with innovators in the
continents.
canceragainst
center" Backedand to byserve
Pfizer resources, we
of deliver technical
fight
About Amgenserious illness.asAmgen’s
Biosimilars
a member businessthe prestigious
development
National
team bringsComprehensive
together deepCancer scientific, Network.
financial, deal,
Cytiva is a global provider of technologies and services that
partnership, and integration expertise—along with an ability
help advance
Bristol Myersand accelerate
Squibb the development
is a leading global biopharma and company
manufacture
focused of therapeutics. Previously GE Healthcare Life
Our mission is to benefit the health and well-being innovative
on discovering, developing and delivering of
Sciences, Cytiva’s
medicinesbyforcontributing diverse
patients with serious portfolio includes
diseases. well-recognized
Ourofpeople
mankind
OHSU's singular focus ontoimproving an adequate supply
health starts safe, are
with
focused onfood
nutritious helpingand millions
by promoting of patients
the around the
emotional and world in
physical
Oregonians
We are looking and for hasmanufacturing
global impact. technologies,
We are the only academic
capacities,
benefits
health arising
center in from
Oregon, the human-animal
but we'regene, bond.
also nationally We are
distinct
and expertise
RemeGen hasin DNA
built synthesis,
a robust portfolio incell therapy
autoimmue, and as a
university dedicated
antibody manufacturing solely to advancing
spaces. We with health
are looking sciences.
for in-IP and This
oncology
Aptar Pharma ADC,is and ophthalmology
a leading provider of innovative independant drug
licensing, co-development
ample manufacturing capacity.and any other kind of strategic
delivery
Alnylam systems
(Nasdaq:ALNY) to pharmaceutical,
is leading consumerthe translationhealthcare
of RNA and
biotech
interferencecustomers worldwide, enabling safe, convenient and
Nomura is a (RNAi) leading into global a new class services
financial of innovativegroupmedicines
with over
compliant
with the medication
potential to delivery.
improve theTrusted
lives ofpartner
people ofafflicted
the
26,000 employees
BeiGene is a global, in science-driven
30+ countries. biotechnology
We act as a financial company
with
advisorraretogenetic,
identifycardio-metabolic,
and facilitate hepatic
strategic infectious,
merger and and
focused
Inspired on by developing
Mayo Clinic’s innovative
history and affordable
of collaboration, medicines
we work
acquisition,
to support
improve treatmentsale of business
outcomes or alliance
and access opportunities
for patients for our
to
Establishedresearchin 1995,and development
Evercore (NYSE:teams EVR)within the
is a leading
worldwide. Withbiotech,
pharmaceutical, a broad and portfolio
inbanking
vitroof diagnostics
more than 40 clinical
industries
global
Catalent independent
Biologics’ investment
drug substance advisory and
development firm.
and their
Evercore collaborators,
advises a diverse such as CROs.
set of advanced
investmentThis includes
banking clients
manufacturing services leverage technology and
on a wide range of transactions
proven expertise to help clients meet their biologicsand issues and provides drug
substance needs. Our development teams collaborate closely
The 8th largest veterinary pharmaceutical company in the
world,our
Since Vetoquinol
foundingisinfirst and
1978 as foremost
one of theanworld’s
independent,
first global
family-owned
biotechnology business.
companies Vetoquinol is solely dedicated to
Zoetis is a leading Animalby Charles
Health Weissmann,
company, Heinz
dedicated to
animal health,
Schaller, Kennethand focused
Murrayand on the
andtheir licensing,
Nobel development,
Prize winners Walter
supporting its customers businesses. Building on
Gilbert
more and65
than Phillip
years Sharp, Biogen has
of experience, led innovative
we deliver quality
medicines, vaccines and diagnostic products, complemented
 News

https://www.marketwatch.com/investing/stock/688553?
countrycode=cn
https://www.kindevadd.com/news/kindeva-drug-delivery-
launches-new-analytical-services-global-business-unit/

https://www.nvidia.com/en-us/industries/healthcare-life-
sciences/
For the latest news about Battelle and our initiatives, please
check out our
Bio Panels newsroom:
with NIH SBIR/STTR Program Staff
Build Your Product Pipeline with Non-Dilutive Federal
Resources Tuesday, June 04, 2024, 11:00 AM - 12:00 PM
https://www.evivebiotech.com/en/news/index
https://en.yifanyy.com/
Press releases: http://ir.novavax.com/press-releases

Created Keytruda, Opdivo, Lynparza, Xenleta, Breztri, Taltz,

Mounjaro, Skyrizi, Rinvoq and 1,000 other brands.
Publicis Sapient is a digital transformation partner helping
established organizations get to their future, digitally-enabled
state, both in the way they work and the way they serve their
https://www.ppd.com/newsroom/
customers. We help unlock value through a start-up mindset
Recombinant Antibody Network (RAN) Partners with Bristol
Myers Squibb to Develop Novel Therapies

EVERSANA Expands Global Commercialisation

Capabilities and Strengthens Agency Network with
https://www.sigmaaldrich.com/US/en/collections/press
Healthware Group Acquisition
CARVYKTI(TM) (ciltacabtagene autoleucel), BCMA-
directed CAR-T therapy, receives U.S. FDA approval for the
treatment of adult patients with relapsed or refractory
https://news.uchicago.edu/story/uchicago-medicine-breaks-
multiple myeloma. February 28, 2022.
ground-states-first-freestanding-cancer-center
Current Projects
BSL-3 Lab - under construction at New Iberia Research
Center (CRO)
https://www.newsweek.com/rankings/worlds-best-hospitals-
2023

https://biologics.catalent.com/biologics/drug-substance/
bioconjugate-development/bioconjugate-advisory-board/

TrakCel Partnership:
https://newsroom.cardinalhealth.com/2023-06-29-Cardinal-
Health-collaborates-with-TrakCel-to-streamline-cell-and-
gene-therapy-commercialization

https://hcahealthcaretoday.com/2024/02/22/hca-healthcares-
sarah-cannon-cancer-institute-implements-new-outpatient-
model-for-car-t-cell-therapy/
NNIT acquired Excellis Health Solution as of November
2020 and is part of the Novo Holdings portfolio of
companies.
CTI's North American and European Laboratories now have
PBMC processing with RNA/DNA extraction capabilities.

TGEN COVID-19 VARIANT TRACKING PROGRAM

RECEIVES GRANT FROM TAIWAN SEMICONDUCTOR
MANUFACTURING CO.
For all the latest news and more information about partnering
with AbbVie CMO, please visit:
https://www.abbviecontractmfg.com
For all the latest news and more information about partnering
with AbbVie, please visit:

https://www.forbes.com/companies/cspc-pharmaceutical-
group/#27b72f426392

https://www.sri.com/press/story/sri-works-with-n4-pharma-
to-target-and-treat-cells-in-the-human-body-that-had-been-
unreachable/
https://frederick.cancer.gov/news
https://innovation.princeton.edu/news/2022/student-
entrepreneur-makes-impact-womens-health

Over two decades since Haisco’s inception, Haisco has

dedicated itself to progress and to making meaningful
impacts in both the pharmaceutical field and the wider
community.
https://ventures.yale.edu/node/88
http://www.elanco.com/news-media/default.aspx

Meet 26 accomplished K-BIO companies that are leading the

country's biotech industry via One-on-One Partnering
program. Check out our global marketplace page to learn
more about each company and schedule your virtual meeting.

https://news.revvity.com/press-announcements/press-
releases/press-release-details/2023/Revvity-Announces-New-
http://www.cytiva.com
License-Agreement-for-Next-Generation-Base-Editing-
Find yourand
nextSecarna
career with Cytiva
Celanese Pharmaceuticals Enter into RNA
Technology/default.aspx
https://www.cytivalifesciences.com/en/us/careers
Research Collaboration for Long-Acting Antisense Therapies

Inotiv, Inc. Expands Protein/Peptide Bioanalytical

Capabilities with Acquisition
SMC Ltd. announces expansionof of
Protypia, Inc.finish
sterile fill
capabilities, unveiling state-of-the-art facility in North
Carolina. The facility enables SMC to offer a wider portfolio
of services to its pharma clients including lab to market

https://www.westpharma.com/news-and-events

https://pci.com/new-sterile-fill-finish-capabilities-now-
available-in-san-diego

http://www.cytiva.com

https://www.newsweek.com/rankings/worlds-best-hospitals-
2023
https://biologics.catalent.com/biologics/drug-substance/
bioconjugate-development/bioconjugate-advisory-board/
Vetoquinol won Animal Pharma's award for best
Euroopeanawaras been awarded best Animal Health
company in European company in 2020
 Primary therapeutic area(s) Secondary therapeutic area(s)

Infectious disease
Neoplasm
Endocrine disease
Aging

Inflammatory disease Fatigue

Prostate tumor
Degeneration Aging
Endocrine disease

Cardiovascular disease
Endocrine disease

Cardiovascular disease Dermatological disease

Hematological
Dermatologicaldisease
disease Genitourinary
Cardiovasculardisease
disease
Gynecology
Viral infection obstetrics
and Degeneration
Vaccination
Cardiovascular disease
Gastrointestinal disease

Andrology Cardiovascular disease

Degeneration Dermatological disease

Respiratory disease
Prostate tumor disease
Cardiovascular
Dermatological disease

Hematological disease
Neoplasm
Andrology
Cardiovascular
Gastrointestinaldisease
disease
Genetic disorder
Cardiovascular disease
Dermatological disease
Cardiovascular disease
Genetic disorder

Neurological disease
Psychiatric disorder
Endocrine disease Dermatological disease
Growth disorder Gastrointestinal disease

Cardiovascular disease
Dermatological disease
Hyperparathyroidism
Stomach infection
Neoplasm
Skin allergy
Gastrointestinal disease
Genetic disorder
Hot flashes
Hormone deficiency

Dermatological disease Infectious disease

Infectious disease Prostate tumor
Cardiovascular disease
Inflammatory
Dermatologicaldisease
disease Inflammatory disease
Bullous
Neoplasmskin disease
Neurological disease
Diabetes mellitus
Obesity
Cardiovascular disease
Endocrine
Andrology disease
Cardiovascular
Gastrointestinaldisease
disease
Cardiovascular disease Respiratory distress syndrome
Dermatological disease
Neoplasm
Skin tumor
Infectious disease
Inflammatory
Cardiovasculardisease
disease
Neurological disease
Dupuytren contracture
Immune disorder
Infectious
Endocrine disease
disease
Hematological
Cardiovascular disease
disease
Endocrine disease
Andrology
Cardiovascular
Cardiovascular disease
disease
Endocrine disease
Cardiovascular disease
Dermatological disease
Neurological disease
Infectious disease Respiratory disease
Respiratory disease Respiratory tract tumor
Genetic disorder
Inflammatory disease
Hematological disease Genetic disorder
Metabolic disorder Immune disorder
Hematological disease
Immune disorderdisease
Dermatological Genetic disorder
Genetic disorder
Metabolic disorder Hematological disease
Neurological disease
Cardiovascular disease Gynecology and obstetrics
Endocrine disease
Cardiovascular disease Hematological disease
Unidentified indication
Degeneration Toxicity and intoxication
Cardiovascular disease
Degeneration
Cardiovascular disease
Dermatological disease
Cardiovascular disease
Dermatological disease
Hematological disease
Immune disorder
Dermatitis
Atopic dermatitis
Cardiovascular disease Genetic disorder
Degeneration
Cardiovascular disease Gynecology and obstetrics
Endocrine disease
Cardiovascular disease
Hematological disease

Cardiovascular disease
Endocrine disease

Neoplasm
Inflammatory disease
Rheumatoid
Inflammatoryarthritis
disease
Neurological disease
Cardiovascular disease
Degeneration
Andrology
Cardiovascular disease

Genetic disorder Growth disorder

Metabolic
Andrologydisorder Musculoskeletal disease
Cardiovascular disease
Cardiovascular disease
Dermatological disease
Degeneration Cardiovascular disease
Inflammatory disease Infectious disease
Gynecology and obstetrics

Hematological neoplasm
Cancer
Cardiovascular disease
Gastrointestinal disease
Cardiovascular disease
Inflammatory disease
Hematological disease
Neoplasm
Infectious disease Mitral valve disease
Musculoskeletal disease
Cardiovascular disease Diabetes mellitus
Hematological disease
Endocrine disease Metabolic disorder
Systemic lupus erythematosus
Advanced solid tumor
Genetic disorder Cardiovascular disease

Neoplasm Immune disorder

Cancer
Andrology
Cardiovascular disease
Infectious disease Urinary tract disease
Inflammatory
Genetic disease
disorder Urogenital tract infection
Aging
Gastrointestinal disease
Gynecology and obstetrics
 Number of employees Founded Ownership Licensing objectives

More than 10,000 1864 Public

1,000 to 10,000 1821 Private Seeking investment
1,000 to 10,000 2010 Public Seeking in-licensing opportunities
1,000 to 10,000 2001 Private Seeking out-licensing opportunities
1,000 to 10,000 Private
1,000 to 10,000 1956 Public Seeking out-licensing opportunities
More than 10,000 1849 Public Seeking investment
1,000 to 10,000 1998 Public
More than 10,000 1993 Public
1,000 to 10,000 1929 Private Seeking out-licensing opportunities
More than 10,000 Other
1,000 to 10,000 1928 Private
More than 10,000 1970 Public Seeking out-licensing opportunities
1,000 to 10,000 2003 Public Seeking in-licensing opportunities
1,000 to 10,000 1987 Public Seeking out-licensing opportunities
More than 10,000 1980 Public
More than 10,000 1999 Private
More than 10,000 Public
1,000 to 10,000 1960 Public
1,000 to 10,000 1972 Public
More than 10,000 1985
More than 10,000 1873 Other Seeking out-licensing opportunities
More than 10,000 1824 Private Seeking investment
More than 10,000 Public Seeking in-licensing opportunities
1,000 to 10,000 2019 Private Seeking in-licensing opportunities
More than 10,000 1668 Public Seeking out-licensing opportunities
1,000 to 10,000 2014 Public Seeking in-licensing opportunities
More than 10,000 2001 Public Seeking out-licensing opportunities
1,000 to 10,000 1890 Private Seeking out-licensing opportunities
More than 10,000 1935 Public
1,000 to 10,000 1898 Other Seeking investment
More than 10,000 1988 Public
More than 10,000 1864 Other
More than 10,000 Public Seeking in-licensing opportunities
More than 10,000 1891 Public Seeking investment
More than 10,000 1999 Public Seeking out-licensing opportunities
1,000 to 10,000 1997 Public Seeking out-licensing opportunities
More than 10,000 1982 Public Seeking in-licensing opportunities
More than 10,000 1971 Public
1,000 to 10,000 Public Seeking in-licensing opportunities
1,000 to 10,000 1984 Seeking
Seeking out-licensing
out-licensing opportunities
opportunities
More than 10,000 1865 Public
More than 10,000 Public
1,000 to 10,000 1994 Public
1,000 to 10,000 Public Seeking in-licensing opportunities
1,000 to 10,000 2002 Public
1,000 to 10,000 1999 Private
1,000 to 10,000 Public
More than 10,000 1990 Public
1,000 to 10,000 1987 Private Seeking in-licensing opportunities
More than 10,000 Other Seeking investment
1,000 to 10,000 1885 Private
1,000 to 10,000 2008 Public Seeking out-licensing opportunities
More than 10,000 2013 Public
1,000 to 10,000 1983 Other Seeking out-licensing opportunities
More than 10,000 2013 Public
1,000 to 10,000 1988 Public
1,000 to 10,000 1908 Private Seeking in-licensing opportunities
More than 10,000 1938 Public Seeking out-licensing opportunities
1,000 to 10,000 1998 Public Seeking out-licensing opportunities
More than 10,000 1863 Public Seeking in-licensing
Seeking investment opportunities
More than 10,000 1787 Other Seeking
Seeking out-licensing
out-licensing opportunities
opportunities
1,000 to 10,000 1893 Public Seeking out-licensing opportunities
More than 10,000 1817 Other Seeking investment
More than 10,000 1971 Public Seeking investment
More than 10,000 Seeking out-licensing opportunities
More than 10,000 1883 Private Seeking out-licensing opportunities
More than 10,000 1958 Private Seeking in-licensing opportunities
1,000 to 10,000 Private Seeking
Seeking out-licensing opportunities
in-licensing opportunities
1,000 to 10,000 1899 Private Seeking out-licensing opportunities
1,000 to 10,000 1997 Public
More than 10,000 1876 Public Seeking in-licensing opportunities
1,000 to 10,000 2008 Private
1,000 to 10,000 1946 Private Seeking out-licensing opportunities
More than 10,000 1876 Public Seeking
Seeking investment
out-licensing opportunities
1,000 to 10,000 1937 Public Seeking out-licensing opportunities
1,000 to 10,000 1972 Other
1,000 to 10,000 1746 Private Seeking out-licensing opportunities
More than 10,000 Public
More than 10,000 1781 Public
1,000 to 10,000 1992 Public Seeking in-licensing opportunities
1,000 to 10,000 Private
1,000 to 10,000 2009 Public Seeking out-licensing opportunities
1,000 to 10,000 1988 Public Seeking in-licensing opportunities
1,000 to 10,000 2000 Public Seeking
Seeking out-licensing
out-licensing opportunities
opportunities
More than 10,000 1870 Public
More than 10,000 1888 Public Seeking in-licensing opportunities
1,000 to 10,000 1701 Private Seeking out-licensing opportunities
More than 10,000 1962 Other Seeking out-licensing opportunities
More than 10,000 1968 Public Seeking in-licensing
Seeking investment opportunities
1,000 to 10,000 1954 Public Seeking out-licensing opportunities
1,000 to 10,000 1989 Private
1,000 to 10,000 1962 Seeking out-licensing opportunities
1,000 to 10,000 1991 Public Seeking investment
1,000 to 10,000 Other
1,000 to 10,000 Public Seeking in-licensing opportunities
More than 10,000 1896 Private
More than 10,000 2023 Public Seeking out-licensing opportunities
More than 10,000 2020 Public Seeking in-licensing opportunities
More than 10,000 1918 Public Seeking out-licensing opportunities
1,000 to 10,000 2020 Private Seeking in-licensing opportunities
1,000 to 10,000 2002 Seeking in-licensing opportunities
More than 10,000 1994 Public Seeking
Seeking out-licensing
investment opportunities
More than 10,000 1987 Public Seeking in-licensing opportunities
More than 10,000 1901 Public Seeking in-licensing opportunities
1,000 to 10,000 1974 Public
1,000 to 10,000 1988 Private
More than 10,000 1923 Public
1,000 to 10,000 1999 Private
1,000 to 10,000 1998 Public Seeking in-licensing opportunities
More than 10,000 1924 Private Seeking out-licensing opportunities
1,000 to 10,000 1923 Public Seeking in-licensing opportunities
More than 10,000 Public Seeking in-licensing opportunities
1,000 to 10,000 1976 Other Seeking out-licensing opportunities
1,000 to 10,000 1970 Private
1,000 to 10,000 2002 Private
More than 10,000 1848 Public
1,000 to 10,000 1898 Private
More than 10,000 1980 Public
More than 10,000 1980 Public
1,000 to 10,000 2020 Public Seeking in-licensing opportunities
More than 10,000 1858 Public Seeking in-licensing
Seeking out-licensingopportunities
opportunities
1,000 to 10,000 1885 Private Seeking out-licensing opportunities
More than 10,000 1887 Other Seeking out-licensing opportunities
1,000 to 10,000 2002 Public Seeking in-licensing opportunities
1,000 to 10,000 2008 Public Seeking out-licensing opportunities
More than 10,000 Public
1,000 to 10,000 2002 Public
More than 10,000 1925 Public
1,000 to 10,000 2011 Public Seeking in-licensing opportunities
More than 10,000 1864 Other
1,000 to 10,000 1995 Public
More than 10,000 1999 Public Seeking out-licensing opportunities
1,000 to 10,000 1933 Other Seeking in-licensing opportunities
1,000 to 10,000 1978 Public
1,000 to 10,000 2013 Public Seeking in-licensing opportunities
 Company objectives Ticker

1. Seeking for out-licensing/partnering opportunities for our 688553 China: Shanghai

innovative fIrst in class ADC, tri-spefic T-cell engager, a
small molecule, dual inhibitor targeting KRAS G12C/PI3K,
which is currently in clinical phase I study. We also open to
Out-license technologies and find investors for startup
companies
Looking to collaborate with biopharmaceutical companies to PFE
support yourmission
Emergent’s productisfrom development
simple – to protectthrough commercial
and enhance life by EBS
launch. Looking
delivering to mind
peace of meet inwith
an investment bankers
uncertain world. and
Emergent is
consulting companies who may have contacts
a global life sciences company focused on providing in need of
Connect with pharmaceutical and biotech organizations
specialty products for civilian and military populations that
interested in PNPs as an alternative to AAV and LNP based
delivery solutions for genetic payloads.
Merger, acquisition or strategic partnership
Collaborate with partners with complementary capabilities to 600276
help accelerate
Inward our global
opportunities: smalldevelopment
molecules orstrategy
biologicals (CHO-
based preferred) in late clinical development stages with NVAX
focus on hematology, dermatology, hepatology, endocrine
AMGN
tumor, inflammatory diseases, metabolic disorders
Support our customers with end-to-end solutions from early
clinical development all the way through to product launch NYSE
and commercialisation.
To help life science professionals understand the value of
their assets and/or company.
We seek industry partners to bring our promising healthcare
technologies to thelicensees,
Seeking potential market, whether
researchit’s a new drug
collaborators,
molecule, diagnostic,
entrepreneurs and medical
investors device
to develop or digital
and health
Evonik partners with the world's foremost , license Jefferson's EVIKIF
pharmaceutical,
application. UCSF
innovations in multiple is also seeking
therapeutic collaborations
areas, clinical and
trial larger-
biotechnology and medical device companies
Commercialization Partnerships - US, Europe, Canada, Asiato develop and
sponsors, and investors in Jefferson's biotech
commercialize innovative products that meet unmet medicaland medtech
Our aim is to accelerate the development and manufacturing MKKGY
needs result in improved treatment for patients.
of your therapeutic
Collaboration, from pre-clinical
partnership, to commercial
in-licensing, out-licensing stages, LEGN
all the while providing risk-mitigating solutions.
Our goal is to help you speed time to market and maximize COR
your product's success
The University of Chicago has 3 main objects:
1. strategic collaborations
- Partnering with innovators and engagements
and with our in the CIPLA
Specialty companies
researchers
therapeutic and startups,
segments including meeting
of Anti-Infectives/AMR, with service
- Expand CRO collaborative partnerships, including new
providers
Respiratoryfor our newest
,Immunology, incubator space, Hyde Park Labs -
BSL-3 and cGLP facilities.Cardiology , Diabetes and REGN
launcing
Oncology. in 2024
Creating strategic partnerships with drug development and
IVD companies by leveraging Mayo Clinic's JNJ
MRK
To meet with potential clients and partners interested in CTLT
speeding your path to market with our range
Top Player in the Pediatric Medicines, Women's Health, of advanced
technologies and
Endocrinology in services
Greater Integrated Solutions:
China/Asian
Our goal is to help biotechs reduce risk,Pacific Area.time
accelerate Topto IQVIA
Specificity
market and Pharm
increase in USA.
peak sales
We want to be your partner in expertly navigating the CAH
complex
We and evolving
are primarily interested in in-licensing opportunities for BHC
the US, Canada,
Creating and LATAM
a dedicated in Gastroenterology,
chip or engineering a smart productCNS,
Dermatology,
requires and rare diseases.
exceptional
We Create Chemistryinfrastructure and knowhow. That’s
where a trusted partner such as imec comes in. Speeding up
Showcase how Best Buy Health’s digital health platform and BBY
your development. De-risking the process. And supporting
comprehensive services to support the safe and effective
delivery of care at home for clinical trial participants.
 CPH: NNIT
Organon has a portfolio of more than 60 medicines and OGN
products
The focusacross
at thisaconference
range of therapeutic
will be to areas.
look forLedinby the
licensing AMRX
women’s healthKey
opportunities. portfolio coupled with an(mainly
expanding
To Support biotech from emerging to commercial size area
focus areas are CNS in the
biosimilars
of Parkinson'sbusiness andmigraine,
stable franchise of established
across multipledisease,
therapeutic areas andand indications,
movement disorders)
from MRK
endocrinology, oncology, and women's
preclinical assay development to registration. health indications.
ICON Medical Device & Diagnostics (MDDR) focuses on
providing best in class
Noven is seeking medical
products for device product
potential development,
in-licensing,
regulatory and
partnering, clinical, post opportunities
or co-promotion market services to to companies
strengthen their
Meet bio-innovators with interest in expanding their global
that do not
current want in
pipeline to ADHD,
risk errors by small scale
Schizophrenia, CROs
and what
Digital
footprint
Strategic and/or collaborating
Alliances, Sponsoredwith bio leaders
Research, and
Cultivating
Therapeutics.
organizations in Phoenix, Arizona.
Relationships, Multi-Year Collaborations, Affiliation DNA
Agreements, Strategic Alliances
We welcome the opportunity to meet with potential partners ABBV
to
Toget to know
advance you and
military for youfor
medicine to get
the to knowofAbbVie
benefit militaryCMO.
and
Our team
civilian is ready
health. to share our capabilities and discuss your
We welcome the opportunity to meet with potential partners ABBV
manufacturing needs.
to get
To to know
provide you and
seamless for youto
solutions toour
get customers
to know AbbVie. Our
to help them PEL
team is ready
accelerate theirtopreclinical,
share our capabilities
clinical, andand discuss innovative
commercialization
LEO Pharma is looking for new differentiated and protected
new partnership opportunities that align with our
programs.
product opportunities
- Partnering in medical
for the global dermatology indications of
development/commercialization HKEx.: 01093
including orphan dermatology indications.
CSPC's innovative Oncology and CNS assets LEO is looking
SHA: 603087
for both global and territorial opportunities, especially for
BAYN
To explore partnership opportunities
Tsumura is seeking partnering opportunities to facilitate our 4540 Tokyo
late-phase clinical development program indicating
postoperative ileus, and then the future NDA.

industry collaborations including licensing, sponsored

research,
1. Seeking alliances, co-development,
In-license newlate-stage
opportunities for ventures,clinical
etc.
assets in the
In-license areasacquire
and/or of oncology, cardiovascular,
innovative treatments for
cerebrovascular,
orthopedic, andand
urology CNS dieseases. indications and in
endocrinology
-Out-license National Jewish Health intellectual property to
targetedand
pharma synergistic
biotech specialty
partners. therapeutic areas for
In-license drug candidates for treatment of rare diseases BMRN
commercialization in the US market.
PARTNERING LLY
At Lilly,
Help our we takebring
clients smarttheir
risksdrugs
on bold scienceintoa discover
to market cost-
treatmentsand
effective andimpactful
cures, allmanner.
for one reason – patients. As a
SRI's focus is to partner with commercial companies to co-
community of scientists, we recognize our responsibility as
develop newLicensing
Technology therapeutics utilizing our novel, first in class
partners to help advance innovative medicines within our
platforms and programs.
Venture Investment We work to solve the toughest
/ Co-Investment 4403
technological problems and create differentiated solutions

We support the Princeton community in their innovation and

entrepreneurial
Evonik partnersgoals as they
with the translate
world's their, discoveries
foremost and
pharmaceutical, EVIKIF
inventions into technologies and services that have
biotechnology and medical device companies to develop and a positive
4502
impact on society.
commercialize innovative products that meet unmet medical
ALXN
needs result in improved treatment for patients.
At Curia, assuring quality, safety and compliance is our top
priority. Ourout-licensing
Seeking for unwavering commitment is toassets,
of clinical stage provide our and
clinical HK2315
customers
strategic with products and services that meet the highest
Companyearly stage
aspires collaboration
to grow through BD deals and partnering, INSM
standards for excellence in global regulatory compliance and
weBecome
1. are highly
theacquisitive
most trustedand looking for pharmaceutical
international either in-licensing 002653
or acquiring assets that are in early-stage, late-stage, or
enterprise. NYSE:DB
commercially approved that could treat patients with rare
NO MEETING REQUEST FROM CROS, CMOS, OR NYSE: ABT
OTHER
PartneringSERVICE PROVIDERS
of life sciences PLEASE.
technology: licensing, discovery
alliances, commercially-supported research for assets in all
phases of discovery and development, venture funding,
entrepreneurs, collaboration.
Seeking to build partnerships via licenses, options, strategic
research collaborations, joint ventures and company LUPIN
formation with biotech/pharma/venture groups.
ELAN

INCY

SRPT

Partnering and out-licensing discussions focused on cell and RVTY

gene therapy
Our job Pin-point
is to supply thebase
toolsediting, AAV our
and services viralcustomers
vector
delivery
need and LentiBOOST
to work better, transduction enhancer
Continue to grow ourfaster and
VitalDose safer,
Drugleading to better
Delivery patient CE
platform
outcomes.
through durable and bioresorbable polymer offerings to
engage in collaborative partnerships that yield innovative
Seeking for in-licensing cell and gene therapy research and
drug products. Our aim is to partner with pharma to improve
manufacturing tech, genepipelines
Grow innovation-driven editing, biologics
and drive production tech,
late-stage asset 600196， 02196
AI in biologics drug discovery or protein based products etc.
launch GILD
TEVA
Network with key industry influencers. NOTV
Explore opportunities to collaborate and serve as an
innovation partner with other service providers.
API Synthesis/Manufacturing, analytic services and solid
state chemistry.
In-license Preclinical
in-clinic to commercial.
and/or commercial assets in the neuro- PTCT
metabolic space, and
- Strategic Partnershipsorphan disease space in general.
-Discussions
Sponsored with
Research
interested partners, where we can apply our WST
expertise in drug packaging and delivery VTRS

Your bridge between life-saving therapies and patients.

NO SERVICE PROVIDER REQUESTS PLEASE
Looking to acquire or license
Identify opportunities mid-late
to provide stage
contract development
development and
assets or approved products
manufacturing services (CDMO) to biotechs
AMGN
AMGN
To find opportunities for partnership that will help Cytiva
turndiscover,
To innovative technologies
develop into innovative
and deliver great products.
medicines that BMY
help patients prevail over serious diseases
We are seeking small molecule and biotherapeutic
approaches
Identify newtobusiness
therapeutic areas identify
partners, of interest including
new arthritis,
out-licensing
pain, allergy,
opportunities, cardiology,
identify new renal failure, oncology and
opportunities for the startup
Life science technology provider HKG:1548
endocrinology.
companies coming Weout
areofalso
ourseeking to in-license anti-
university.
RemeGen is primarily seeking strategic-fit partners to HKG 9995，SSE STAR Market 688331
expedite development and commerialziation of our pipeline ATR
ex-China.
ALNY
We are interested in connecting with biotech and pharma 8604-JP
companies across
Discover the next all therapeutic
generation areas that
of cancer are seeking
treatments BGNE
M&A, licensing / partnering or equity capital markets
Creating strategic partnerships with drug development and
transactions.
IVD companies by leveraging Mayo Clinic's EVR
To meet with potential clients and partners interested in CTLT
speeding your path to market with our range of advanced
technologies and services Integrated Solutions:
In-licensing or acquisition of technologies applicable to VETO:EN
veterinary medicine, in the areas of our strategic interest. BIIB
Our research alliance interests include: antibiotic ZTS
alternatives, immunomodulation, antiparasitics, pain,
inflammation, livestock health and chronic diseases in
companion animals as well as various technologies in the
Market cap ($M) Last funding round(s) Total funding ($M)

160

40000

Other

7100

A Round
F Round

8000

516.5
6000

82000

18000

1595
 3000

14000
4000

5600

20000

3978

36630

1500 400
4000
5000

215912
0
 9000

16000

12780

17971

8000
10000

3000

4600
5700

12096
15630 Other

18000
 Website Main email

https://www.gerresheimer.com/en/home [email protected]

http://www.seacrosspharma.com/ [email protected]
www.propharmagroup.com
https://www.kindevadd.com/ [email protected]
https://www.usf.edu/research-innovation/pl/ [email protected]
www.pfizercentreone.com [email protected]
https://www.emergentbio.com
https://www.nvidia.com/
www.battelle.org [email protected]
seed.nih.gov [email protected]
http//www.lubrizol.com [email protected]
https://www.hengrui.com/en/index.html [email protected]
http://en.yifanyy.com/ [email protected]
http://www.novavax.com
www.amgen.com
www.syneoshealth.com [email protected]
avantorsciences.com [email protected]
http://publicissapient.com/
https://www.hl.com/us/ [email protected]
https://www.ppd.com/ [email protected]
https://innovation.ucsf.edu/ [email protected]
https://www.jeffersonhealth.org
www.evonik.com/parenteral [email protected]
https://www.eversana.com/solutions/ [email protected]
https://www.sigmaaldrich.com/US/en/services/contract-manufacturing/viral-vector-manufacturing
http://www.legendbiotech.com/ [email protected]
www.cencora.com
www.uchicago.edu [email protected]
https://www.cipla.com [email protected]
https://nirc.louisiana.edu [email protected]
www.Regeneron.com
https://news.mayocliniclabs.com/biopharma/
https://jnjinnovation.com/
www.merck.com/licensing [email protected]
www.catalent.com [email protected]
http://www.genscigroup.com [email protected]
https://www.iqvia.com [email protected]
https://www.cardinalhealth.com/regulatory
www.bauschhealth.com [email protected]
https://www.imec-int.com/en/lifesciences [email protected]
bioservices.basf.com [email protected]
www.bestbuyhealth.com
https://www.nnit.com/ [email protected]
www.organon.com [email protected]
amneal.com
www.ctifacts.com [email protected]
www.merck-animal-health-usa.com
www.iconplc.com [email protected]
http://www.noven.com/index.php
www.PHXisBIO.com [email protected]
http://smir.stanford.edu [email protected]
http://ginkgobioworks.com [email protected]
www.abbviecontractmfg.com [email protected]
https://innovations.hjf.org [email protected]
www.abbvie.com [email protected]
http://www.piramalpharmasolutions.com [email protected]
www.leo-pharma.com
https://www.cspc.com.hk/en/global/home.php [email protected]
http://www.ganlee.com [email protected]
www.bayer.com
https://www.oiep.pitt.edu/ [email protected]
https://www.tsumura-usa.com/
innovation.medicine.umich.edu/business-development/ [email protected]
https://www.mdanderson.org/
https://www.emdgroup.com/en/partnering/collaboration-in-healthcare.html
innovation.cincinnatichildrens.org [email protected]
http://en.qilu-pharma.com/ [email protected]
www.endo.com
www.njhealth.org [email protected]
http://www.bmrn.com/
https://www.lilly.com/partners/connect
www.certara.com [email protected]
https://www.sri.com/ [email protected]
https://www.cuanschutz.edu/cu-innovations [email protected]
www.nofamerica.com [email protected]
Frederick.cancer.gov [email protected]
https://innovation.princeton.edu/ [email protected]
www.evonik.com/parenteral [email protected]
www.takeda.com [email protected]
http://www.alexion.com
curiaglobal.com [email protected]
https://en.biocytogen.com.cn/ [email protected]
http://www.insmed.com/ [email protected]
[email protected]
www.db.com
www.abbott.com
https://ventures.yale.edu/
https://bridge.umassmed.edu/s/ [email protected]
www.lupin.com
www.elanco.com [email protected]
www.miltenyibioindustry.com [email protected]
kotra.or.kr/english/index.do
http://www.incyte.com/
http://www.nhlbi.nih.gov/about/org/dera/otac [email protected]
https://www.sarepta.com/
https://www.gene.com/
www.revvity.com [email protected]
www.cytiva.com [email protected]
https://www.celanese.com/applications/sustained-drug-delivery-technologies
[email protected]
https://resilience.com/
https://www.genscript.com/
https://fosunpharmausa.com/
https://www.gilead.com/
www.tevapharm.com
inotivco.com [email protected]
www.smcltd.com [email protected]
https://www.ecolab.com [email protected]
https://www.cambrex.com [email protected]
www.ptcbio.com [email protected]
https://externalpartnerships.duke.edu/ [email protected]
westpharma.com [email protected]
www.viatris.com
https://www.sbpdiscovery.org/
pci.com [email protected]
www.exeltisusa.com [email protected]
www.pfizercentreone.com [email protected]
www.roswellpark.org/gmp
www.amgen.com
www.amgen.com
www.cytiva.com [email protected]
https://www.bms.com/researchers-and-partners/in-the-pipeline.html
https://www.boehringer-ingelheim.com/partnering/working-together-animal-health/connect-with-us
https://www.ohsu.edu/innovates [email protected]
https://www.genscript.com/ [email protected]
http://www.remegen.com [email protected]
https://aptardigitalhealth.com [email protected]
http://www.alnylam.com/ [email protected]
http://www.nomura.com/ [email protected]
http://www.beigene.com/ [email protected]
https://news.mayocliniclabs.com/biopharma/
http://www.evercore.com [email protected]
www.catalent.com [email protected]
http://vetoquinol.com [email protected]
www.biogen.com [email protected]
zoetis.com [email protected]
 Main phone Country State

+1-986-217-2397 United States New Jersey

United States DC
617-444-8774 United States MA
United States D.C.
651-335-3621 United States Minnesota
813-974-3038 United States FL
United States
United States Maryland
United States California
United States Ohio
301.827.8595 United States Maryland
+1(440)336-2703 United States Ohio
United States New Jersey
United States
(240) 268-2000 United States MD
(805) 447-1000 United States CA
United States NC
United States
1-617-621-0200 United States Massachusetts
+19085914695 United States New York
+6421399529 United States
United States California
800-JEFF-NOW United States PA
1 205 451-7330 United States
+16472620395 United States Pennsylvania
800-645-5476 United States MA
+1 (732)2213170 United States New Jersey
United States
United States Ilinois
+1 5162979199 United States New Jersey
337-212-1185 United States Louisiana
United States NY
United States MN
United States
732-594-4000 United States NJ
858 304 0146 United States California
9739600651 United States Massachusetts
United States
United States Ohio
United States New Jersey
+16179490450 United States California
United States California
914-215-1909 United States MA
+1 (978) 994-5119 United States PA
United States New Jersey
United States NJ
5135826985 United States
United States NJ
+1-302-438-9894 United States
9738608374 United States Florida
602-534-8390 United States Arizona
United States CA
877-422-5362 United States MA
+1-847-938-8524 United States IL
3015490876 United States Maryland
United States IL
+919821020110 United States PA
United States NJ
United States New Jersey
801-450-9153 United States New Jersey
United States
412-383-4163 United States PA
United States
734-615-5060 United States Michigan
(713) 792-2121 United States TX
United States MA
United States Ohio
United States MA
United States PA
United States Colorado
415-506-6700 United States CA
United States Indiana
United States New Jersey
650-656-5482 United States CA
303-724-6653 United States Colorado
914-681-9790 United States New York
301-846-5739 United States Maryland
6092583653 United States NJ
1 205 451-7330 United States
+1 617-444-4424 United States Massachusetts
United States MA
1-518-894-2008 United States New York
United States Massachusetts
(908) 977-9900 United States NJ
United States New Jersey
United States NY
United States Illinois
12034368096 United States CT
508-856-5050 United States Massachusetts
United States NJ
1-3179673872 United States Indiana
United States Maryland
1-212-826-0900 United States New York
1-855-4-INCYTE United States DE
4105914736 United States Maryland
United States Massachusetts
United States CA
United States MA
United States Massachusetts
+1-859-372-3214 United States Texas
United States CA
United States New Jersey
United States NJ
United States CA
United States
United States Indiana
7152473500 United States Wisconsin
800-352-5326 United States Minnesota
United States
+1-908-222-7000 United States New Jersey
(919)660-9575 United States North Carolina
United States PA
+1 724.514.1800 United States Pennsylvania
(858)646-3100 United States CA
United States PA
United States NJ
Drug Product: 1-224-212-2264 or API: 1-269-833-6164 United States NY
United States NY
(805) 447-1000 United States CA
(805) 447-1000 United States CA
United States Massachusetts
United States NY
United States Georgia
503-494-8200 United States OR
+1-732-902-1603 United States New Jersey
United States California
United States MA
617-551-8200 United States MA
3478494649 United States New York
(857) 228-6923 United States MA
United States MN
United States New York
858 304 0146 United States California
+1 (817)470-6374 United States TX
+1 781 464 2000 United States MA
+1 973.822.7000 United States Michigan
 City Street address Postal code

Washington 1922 F ST, NW, 421D 20052

Cambridge 245 First Street 02142
Washington
Woodbury 11200 Hudson Road 55129
Tampa 3702 Spectrum Blvd. Ste. 165 33612
New York
Gaithersburg 300 Professional Drive 20879
NVIDIA, Santa Clara
Columbus

Wickliffe 29400 Lakeland Blvd 44092

Princeton 400 Alexander Park Rd 08540

Gaithersburg 21 Firstfield Road 20878

Thousand Oaks 1 Amgen Center Dr. 91320
Morrisville 1030 Sync Street 27560
Radnor 100 Matsonford Road 19087
Boston
New York 245 Park Avenue, 16th Floor

San Francisco 94158

Philadelphia

Burlington 400 Summit Drive 01803

Piscataway 10 Knightsbridge Road 08854

Chicago 5801 South Ellis Avenue 60637

Warren
Lafayette PO Box 43610 70504
Tarrytown
Rochester 3050 Superior Drive NW 55905
New Brunswick
Rahway 126 East Lincoln Avenue 07065
San Diego 7330 Carroll Road 92121
Cambridge 245 First Street Suite 1800 02142

Dublin 7400 W 110th St, Suite 300 66210

Bridgewater
San Jose 3031 Tisch Way, Ste 125 95128
San Diego 3550 John Hopkins Court 92121
Boston 2 Seaport Lane, Suite 9A 02210
New Hope 4 East Bridge Street, Suite 300 18938
Jersey City 30 Hudson St 07302

Greater Cincinnati 100 E RiverCenter Blvd 41011

Madison 2 Giralda Farms 07940

Miami 11960 SW 144th Street 33186

Phoenix 200 West Washington St., 20th Floor 85003
Palo Alto
Boston 27 Drydock Ave 02210
North Chicago 1401 Sheridan Rd 60064
Bethesda 6720A Rockledge Drive 20817
North Chicago 1 North Waukegan Rd 60064
Riverview 18655 Krause St Riverview MI 48193 USA 48193

Princeton 302 Carnegie Center Blvd 08540

BridgewaterTownship Gan & Lee Pharmaceuticals, USA Corp 520 US Highway 22 08807
East, Suite 302 Bridgewater,
Pittsburgh 3420 Forbes Avenue, 3rd Floor Murdoch Bldg 15213

Ann Arbor
Houston 1515 Holcombe Blvd. 77030
Billerica 45 A Middlesex Turnpike 01821
Cincinnati 3333 Burnet Ave. 45229
Boston 50 Soldiers Field Place 02135
Malvern
Denver 1400 Jackson Street 80206
San Rafael 770 Lindaro Street 94901
Indianapolis Lilly Corporate Center 46285
Princeton
Menlo Park 333 Ravenswood Ave. 94025
Aurora 1890 N. Revere Ct., Suite 6202 80045
White Plains One North Broadway, Suite 912 10601
Frederick P.O. Box B 21702
Princeton 619 Alexander Road, Suite 102 08540

Cambridge 40 Landsdowne St. 02139

Boston 121 Seaport Blvd 02210
Albany 26 Corporate Circle 12203
Waltham 300 Third Ave 02451
BRIDGEWATER 700 US 206 08807-3365

New York 1 Columbus Circle 10019

Abbott Park 100 Abbott Park Road 60064
New Haven 433 Temple Street 06511
Worcester 55 N. Lake Ave. 01545
Somerset 400 Campus Drive 08873
Greenfield 2500 Innovation Way 46140
Gaithersburg 1201 Clopper Rd 20878
New York 460 Park Ave. 14th Fl 10022
Wilmington 1801 Augustine Cut-Off 19803
Bethesda 6701 Rockledge Dr. 20852
Cambridge
South San Francisco
Waltham 940 Winter Street 02451
Marlborough 100 Results Way 01752
Irving 222 West Las Colinas Boulevard 75039
La Jolla
Piscataway 860 Centennial Avenue 08854
Princeton 104 Carnegie Center Drive 08540
Foster City 333 Lakeside Drive 94404

West Lafayette 2701 Kent Ave 47906

Somerset 330 SMC Drive 54025
St. Paul 1 Ecolab Place 55102
New Jersey
South Plainfield 100 Corporate Court 07080
Durham 2812 Erwin Rd, Suite 403 27705
Exton 530 Herman O West Drive 19341
Canonsburg 1000 Mylan Blvd. 15317
La Jolla 10901 North Torrey Pines Road 92037
Philadelphia 3001 Red Lion Road 19114
FLORHAM PARK 07932
New York
Buffalo Elm & Carlton Streets 14263
Thousand Oaks 1 Amgen Center Dr. 91320
Thousand Oaks 1 Amgen Center Dr. 91320
Marlborough 100 Results Way 01752
NY 345 Park Ave 10154
Duluth 3239 Satellite Blvd 30096
Portland 3181 SW Sam Jackson Park Road, Mail Code: L106TT 97239
Piscataway 860 Centennial Ave 08854
San Francisco 650 Gateway Dr, #100 94080
Cambridge
Cambridge 300 Third St 02142
New York 309 West 49th Street, 16th floor 10019
Cambridge 55 Cambridge Parkway, Suite 700W 02142
Rochester 3050 Superior Drive NW 55905
New York 55 East 52nd Street 10055
San Diego 7330 Carroll Road 92121
Fort Worth 4250 N. Sylvania Ave 76137
Cambridge 225 Binney Street 02142
Kalamazoo 333 Portage Street Kalamazoo 49007
 Created date/time Last updated date/time

05/27/2024 8:52 PM 06/03/2024 7:48 PM

05/20/2024 10:42 PM 06/03/2024 8:55 AM
02/23/2024 3:16 AM 06/02/2024 11:45 PM
02/29/2024 2:30 AM 06/02/2024 7:22 PM
03/06/2024 8:25 PM 06/02/2024 5:19 AM
05/03/2024 1:58 AM 05/31/2024 11:24 PM
03/22/2024 1:31 AM 05/31/2024 9:28 PM
05/31/2024 8:20 PM 05/31/2024 8:54 PM
05/30/2024 9:45 PM 05/31/2024 3:44 AM
02/23/2024 2:57 AM 05/31/2024 1:40 AM
03/21/2024 11:14 PM 05/30/2024 11:19 PM
04/17/2024 2:17 AM 05/30/2024 7:49 PM
04/08/2024 10:44 PM 05/30/2024 9:58 AM
05/07/2024 11:27 PM 05/30/2024 12:03 AM
05/21/2024 5:50 AM 05/29/2024 11:10 PM
03/19/2024 7:06 PM 05/29/2024 8:29 PM
03/08/2024 8:09 PM 05/29/2024 3:53 AM
05/29/2024 2:30 AM 05/29/2024 2:32 AM
05/28/2024 10:41 PM 05/28/2024 10:41 PM
05/20/2024 7:25 PM 05/28/2024 9:22 PM
05/02/2024 12:21 AM 05/28/2024 5:48 AM
02/27/2024 6:02 PM 05/27/2024 2:50 AM
04/24/2024 7:29 PM 05/25/2024 2:50 AM
05/08/2024 2:01 AM 05/24/2024 9:31 PM
03/01/2024 8:10 PM 05/24/2024 8:38 PM
03/08/2024 3:40 AM 05/24/2024 2:42 AM
02/27/2024 11:31 PM 05/23/2024 10:44 PM
03/01/2024 1:20 AM 05/23/2024 4:56 PM
03/04/2024 8:12 PM 05/23/2024 9:02 AM
03/01/2024 12:49 AM 05/23/2024 3:54 AM
05/14/2024 8:03 PM 05/23/2024 2:44 AM
04/26/2024 2:49 AM 05/22/2024 6:02 PM
04/12/2024 8:03 PM 05/22/2024 2:19 AM
03/29/2024 11:56 PM 05/22/2024 2:12 AM
03/19/2024 9:34 PM 05/21/2024 7:32 PM
05/21/2024 7:05 PM 05/21/2024 7:05 PM
03/01/2024 10:15 PM 05/21/2024 1:32 AM
03/01/2024 8:51 PM 05/20/2024 7:45 PM
04/04/2024 12:23 AM 05/18/2024 6:15 AM
02/23/2024 2:58 AM 05/17/2024 11:19 PM
04/23/2024 12:24 AM 05/17/2024 7:58 PM
05/02/2024 11:18 PM 05/17/2024 12:39 PM
05/02/2024 9:38 PM 05/17/2024 2:06 AM
05/08/2024 2:50 AM 05/17/2024 12:26 AM
03/20/2024 11:37 PM 05/16/2024 11:47 PM
03/08/2024 1:11 AM 05/16/2024 10:34 PM
04/11/2024 10:32 PM 05/16/2024 8:40 PM
03/19/2024 9:33 PM 05/16/2024 2:24 AM
04/13/2024 12:23 AM 05/15/2024 10:27 PM
05/15/2024 9:10 PM 05/15/2024 9:17 PM
03/27/2024 12:18 AM 05/14/2024 6:39 AM
04/10/2024 12:48 AM 05/14/2024 1:22 AM
03/02/2024 12:04 AM 05/14/2024 12:10 AM
05/13/2024 10:32 PM 05/13/2024 10:32 PM
04/27/2024 2:46 AM 05/13/2024 9:23 PM
02/21/2024 11:12 PM 05/11/2024 10:05 AM
04/25/2024 8:16 PM 05/10/2024 9:52 PM
03/01/2024 8:54 PM 05/10/2024 7:58 PM
03/25/2024 8:14 PM 05/10/2024 7:12 PM
04/25/2024 1:04 AM 05/10/2024 2:16 PM
05/03/2024 8:01 PM 05/10/2024 2:55 AM
03/07/2024 10:27 PM 05/10/2024 12:34 AM
03/21/2024 7:23 PM 05/09/2024 2:05 PM
02/27/2024 5:59 PM 05/09/2024 1:03 AM
03/06/2024 7:47 PM 05/09/2024 12:59 AM
03/05/2024 10:58 PM 05/08/2024 11:03 PM
03/05/2024 10:57 PM 05/08/2024 10:02 PM
02/26/2024 7:44 PM 05/08/2024 12:49 PM
03/01/2024 7:32 PM 05/08/2024 1:23 AM
04/04/2024 12:05 AM 05/08/2024 1:22 AM
05/04/2024 2:31 AM 05/08/2024 12:07 AM
03/23/2024 1:17 AM 05/07/2024 9:58 PM
03/08/2024 1:16 AM 05/07/2024 4:35 AM
02/23/2024 3:10 AM 05/07/2024 1:04 AM
04/18/2024 1:06 AM 05/07/2024 12:18 AM
05/06/2024 11:24 PM 05/06/2024 11:24 PM
05/04/2024 4:56 AM 05/06/2024 11:08 PM
05/06/2024 10:38 PM 05/06/2024 10:38 PM
05/06/2024 9:10 PM 05/06/2024 9:10 PM
03/12/2024 10:20 PM 05/06/2024 8:28 PM
04/02/2024 1:08 AM 05/03/2024 10:11 PM
03/27/2024 1:49 AM 05/03/2024 8:39 PM
03/02/2024 1:25 AM 05/03/2024 6:32 PM
03/25/2024 9:21 PM 05/02/2024 9:10 PM
03/01/2024 9:27 PM 05/01/2024 11:53 PM
03/01/2024 9:16 PM 05/01/2024 8:24 PM
03/20/2024 6:59 PM 05/01/2024 7:59 PM
02/21/2024 2:55 AM 05/01/2024 7:21 PM
04/01/2024 11:00 PM 05/01/2024 12:59 AM
02/29/2024 10:23 PM 04/29/2024 9:41 PM
03/01/2024 7:22 PM 04/26/2024 6:25 PM
04/17/2024 6:34 PM 04/25/2024 11:02 PM
04/20/2024 12:08 AM 04/25/2024 7:17 PM
04/23/2024 11:29 PM 04/23/2024 11:29 PM
04/23/2024 7:14 PM 04/23/2024 7:14 PM
04/23/2024 6:45 PM 04/23/2024 6:45 PM
04/11/2024 12:20 AM 04/22/2024 11:04 PM
04/11/2024 8:05 PM 04/19/2024 2:15 AM
04/12/2024 7:31 PM 04/17/2024 9:29 PM
03/01/2024 1:17 AM 04/15/2024 8:48 PM
04/13/2024 3:18 AM 04/13/2024 3:18 AM
04/11/2024 10:11 PM 04/11/2024 10:11 PM
03/05/2024 11:55 PM 04/11/2024 9:38 PM
04/10/2024 11:51 PM 04/11/2024 3:33 AM
03/05/2024 6:10 PM 04/10/2024 10:27 PM
03/28/2024 1:51 AM 04/10/2024 12:32 AM
04/05/2024 10:47 PM 04/09/2024 7:32 PM
04/05/2024 1:17 AM 04/09/2024 3:46 PM
04/06/2024 2:09 AM 04/06/2024 2:09 AM
03/06/2024 10:23 PM 04/04/2024 7:52 PM
03/27/2024 2:37 AM 04/04/2024 7:48 PM
04/03/2024 6:52 PM 04/03/2024 6:52 PM
02/23/2024 3:01 AM 03/29/2024 10:44 PM
03/29/2024 3:43 AM 03/29/2024 3:43 AM
03/07/2024 3:04 AM 03/27/2024 1:19 AM
03/25/2024 7:22 PM 03/25/2024 7:22 PM
03/22/2024 1:32 AM 03/22/2024 1:32 AM
03/21/2024 7:24 PM 03/21/2024 7:24 PM
03/20/2024 7:11 PM 03/20/2024 7:11 PM
03/19/2024 7:07 PM 03/19/2024 7:07 PM
03/18/2024 5:33 PM 03/18/2024 5:33 PM
03/13/2024 11:28 PM 03/13/2024 11:28 PM
03/11/2024 9:28 PM 03/11/2024 9:28 PM
03/08/2024 6:48 PM 03/08/2024 6:48 PM
03/07/2024 9:12 PM 03/07/2024 9:12 PM
03/06/2024 6:38 PM 03/06/2024 6:38 PM
03/06/2024 6:16 PM 03/06/2024 6:16 PM
03/06/2024 2:24 AM 03/06/2024 2:24 AM
03/02/2024 1:15 AM 03/02/2024 1:15 AM
03/02/2024 12:23 AM 03/02/2024 12:23 AM
03/01/2024 9:33 PM 03/01/2024 9:33 PM
03/01/2024 8:08 PM 03/01/2024 8:08 PM
02/29/2024 11:20 PM 02/29/2024 11:20 PM
02/23/2024 3:01 AM 02/23/2024 3:01 AM
02/23/2024 1:59 AM 02/23/2024 1:59 AM
02/21/2024 2:34 AM 02/21/2024 2:34 AM
 Company Booth NumMeeting stCompany sCompany tBrief descrDescriptio News Primary thSecondary
Bausch Health
Just Companies,
Declined
Inc. Biotech Bausch Cardiovas
BoehringerAttending
3743
IngelheimRequested
Human Pharma or
SPONSO Biotech Health
As a Boehring cular
Cardiovas
without R pharma, world-
or Companie er disease
cular
Illumina Ventures
4035 Investor Illumina Illumina
Booth therapeuti leading,
pharma, s Inc. is a Ingelheim disease
Bayer 1527 Requested BIO (buy-side
Biotech Ventures
Bayer is a Ventures
Bayer is a Cardiovas
therapeuti
or global is a
Cristália 4035 or sell-
Requested BOARD Biotech
invests
Life in invests
CRISTÁL global in
CRISTÁL cular
Dermatol
side
pharma, early-
Science early-
enterprise disease
Genentech Just or IA is a
and RocheRequested SPONSO Biotech Roche is Genentec IA is a ogical
Cardiovas
therapeuti company
pharma, aprivate with
private core disease
Revvity JustAttending Declined R or global h, a
Biotech Revvity is Revvity is https:// cular
without therapeuti pioneer
pharma, owned in member
owned
Attending
Orion Corporation
Just Requested or
Biotech aOrion
life committe
Orion news.revv disease
Breast
Booth
without therapeuti
pharma, pharmace
sciences of the
Attending
Thermo Fisher
3555 Scientific, Inc or
Other Corporati d
Thermo Our
to
Corporati ity.com/ tumor
Booth
without therapeuti
pharma, andon is a partnering
on is a press-
2223
Sanofi— New Jersey Pavilion products Fisher Mission
Booth therapeuti
or European,
Scientific European,
is to
Resilience 5051
services Inc. enable
Thermo Fisher Scientific
5707 — Ohio
Thermo3849
Fisher
— Scientific
South Carolina Pavilion
Thermo Fisher
2223 — Scientific
New Jersey Pavilion
Thermo Fisher Scientific
3555
Thermo811Fisher
— Massachusetts
Scientific Pavilion
Bayer AG 1527
Bayern International
4315 — Germany
GmbH Pavilion
e between BARDA and Johnson2721 & Johnson Innovation - JLABS
akeda Pharmaceuticals
811 — Massachusetts
America, Inc.Pavilion
Takeda Pharmaceuticals
2625 — California
USA IncPavilion
Boehringer Ingelheim 3743
ger Ingelheim3735
Biopharmaceuticals
— EBD Group Pavilion
GmbH
Boehringer Ingelheim
4035 — Brazil
Brasil Pavilion
Pfizer 2327
Vertex Pharmaceuticals
811 — Massachusetts
IncorporatedPavilion
Samsung Biologics 4435
GSK
4023 — Belgium Pavilion
Amgen1711
North
— Carolina
North Carolina Pavilion
AstraZeneca1421
Canada
— Quebec
Inc Pavilion
Lonza 5335
Gilead 4035
Sciences
— Brazil Pavilion
Piramal Pharma Solutions
4613
Biocon California2625
Daiichi Sankyo Co.,
6136Ltd.
RequestedSPONSO Biotech Daiichi Daiichi
Sanofi 2223 RequestedR SPONSO or
Biotech Sankyo
SANOFIis Sankyo
We are an is
pharma, a global dedicated
Alfasigma 4235 Declined R or
Biotech is an
No innovativ
Alfasigm
therapeuti
pharma, pharmace
innovativ to
e isthe
global
BioNTech 4035 Requested or
Biotech BioNTec aBioNTec
service an
therapeuti
pharma, h e global
providers healthcare
Italian
Hypera Pharma 4035- Business
Requested
Forum or is a is h
Biotech Hypera is a
Hypera
therapeuti global,
pharma, meeting global
privately-
2119 RequestedMEMBE or
Shionogi & Co., Ltd. Biotech theSHIONO Pharma,
SHIONO
therapeuti
pharma, clinical
largest next
formerly
FUJIFILM - Exhibitor
5035 Requested R or
Biotech GI is
FUJIFILa GI
About
therapeuti
pharma, fully
research- known
concentra as
Grifols Engineering
4149 or M
SA - Business Forum Biotech Grifols offers FUJIFIL
EXPERIE
therapeuti driven
pharma, Manufacturing
a wide tes on
M Business
Boehringer Ingelheim
3743 Requested
Biopharmaceuticals or
Biotech Engineeri
SPONSO Contract Family- NCE Boehring
therapeuti ng
pharma, range of YOUCorporati
4035 RequestedR
Biolab Sanus Farmaceutica or
Biotech owned
Biolab, a erBiolab is
therapeuti
pharma, specialize
since its CAN
Ingelheim
or leading one of the
therapeuti
pharma, company Biopharm
establish largest
animal in Brazil, Brazilian
Kyoto University6035 Institute, IAC , Kyoto
Evotec 2223 Declined hospital
CMO, Office
Evotec of
is Universit
The
Otsuka Pharmaceutical research
CRO Institution
a life y's
CompanyOffice
4049 Requested
Co., Ltd. SPONSO Biotech Otsuka Otsuka
al
science Pharmace of
leverages
Mitsubishi Tanabe Pharma
4507 Requested R
Corporation or
Biotech Pharmace
Mitsubish Mitsubish
pharma, company
utical its
Taisho Pharmaceutical
5643 Declined
Co., Ltd. or
Biotech iTaishoTanabeis utical
is a iTaisho
Tanabeis
therapeuti
pharma, global
Pharma believes
Pharma
Aché Laboratórios Farmacêuticos
4421 Declined or
S.A. - Business
Biotech a leading Privately-
Forum
Leading a leading
therapeuti
pharma, Corporati
Japanese Corporati
Japanese
Yokogawa Electric Corporation
5607 or
Supplier, Yokogaw owned
Brazilian Yokogaw
therapeuti
pharma, pharmace
pharmace pharmace
company
Acino 4035 Requested engineeri
Biotech Acino is a a Electric
a is
therapeuti looking
ng utical founded
Corporati
Blau Farmacêutica4035 or
Biotech specialty
Blau Blau is a
pharma, forward
biopharm on is a
Pierre Fabre SA 4315 Declined or
Biotech Farmaceu The
Pierre leading
therapeuti
pharma, aceutical
tica is a Brazilian
NITTO DENKO CORPORATION
4311 Declined or Fabre
Biotech Nitto’s is Pierre
Nitto
therapeuti
pharma, private
an pharmace
Fabre
FIOCRUZ/Bio-Manguinhos
4035 or
Biotech Responsi BioPharm
proprietar The
therapeuti y
pharma, independe
delivery aGroup
is a is
Fuji Pharma Co. 1421
Ltd. Requested or
Biotech Tokyo- Institute
ble for Fuji
therapeuti
pharma, platform
technolog clinical
of
Laboratorios Farmaceuticos
5219 RequestedRovi or
Biotech listed
Risvan® Pharma
Company
therapeuti
pharma, ical
specialty Technolo
has been
Kaken Pharmaceutical
4421 Declined
Co., Ltd. or
Biotech Kaken is Descripti
is a >About
therapeuti
pharma, pharma,
monthly enriching
on:
Fresenius Kabi 903 Requested or
Biotech Caring for Kaken
fully- Fresenius
therapeuti integrated
pharma, LAI for
Boehringer Ingelheim
4035 Requested
Human Pharma or
SPONSO Biotech As a the Kabi
Boehringis a
therapeuti
pharma, Japanese
critically global
5607 RequestedR
Hikma Pharmaceuticals or
Biotech world-
Hikma er
We're a
therapeuti
pharma, ill Patient healthcare
leading, Ingelheim
Extrovis AG 4049 or
Biotech Thehelps put global
We are
therapeuti
pharma, global
better is a
company
Novartis 4725 RequestedSPONSO Biotech or Extrovis dedicated
Novartis
therapeuti Group
pharma, health is to withthea
Clinigen 4035 Declined R or
Biotech Clinigen provides Clinigen
therapeuti
pharma, headquart developm
Meiji Seika Pharma
5607Co., Ltd. or
Biotech (Clinigen healthcare
Meiji is a
Meiji
therapeuti
pharma, Group) is solutions
leading
Western University
2525 or
Academic Discover Seika
Seika At
therapeuti
pharma, a global
Pharma, a global
Pharma is
Eurofarma Laboratórios
3823 Requested
SA ,
Biotech Regional Western
tech how Eurofarm
therapeuti Western
transfer “Specialt Universit dedicated
University Health Network
4023 or
Institute, Universit aUHN
Pharma in is the
pharma, excels
Latin in y,
leadranked
Kyorin Pharmaceutical
3424 Declined
Co, Ltd hospital Kyorin
Biotech y Healthis Kyorin consists
animal
research America
Network Pharmace of 7
FUJIFILM Pharmaceutical
4835 Declined
Division or
Biotech aWe are Pharmace FUJIFIL
pharma, (UHN)
research- is world-
utical
JT Pharma 5327 RequestedMEMBE Biotech JTor seeking M
JT
therapeuti out-
pharma, based Co., Ltd.
Holdings
Neuraxpharm 1817 RequestedR or
Biotech NEURAX Pharma,
Pharma is NEURAX
therapeuti
pharma, licensing
dedicated Corporati
the
Asahi Kasei Pharma
2425Corporation
Requested PRESEN or
Biotech PHARM,
Asahi PHARM
AKP is a
therapeuti
pharma, to
a the Pharmace
is a PE-
CureVac SE 4741 TING or Kasei
Biotech ***NO CureVac fully
COMPA therapeuti
pharma, European
Pharma backed integrated
Mochida Pharmaceutical
4217 Requested
Co., Ltd. or
Biotech SERVICE
Mochida is a global
Mochida
NY therapeuti PROVID
pharma, Corporati biopharm pharmace
Insud Pharma 5219 Requested or
Biotech Pharmace
Insud is actively
Insud
therapeuti
pharma, ERS
utical aceutical
seeking
University of Bath
2625 or
Medical Pharma is Universit
The Pharma is
therapeuti
pharma, (Mochida
a leading both
a 2,5 in-
B€
University of Calgary
2625 ACADE Institute, UCalgary y
device or Universit of Bath:
UCalgary
therapeuti pharma
technolog researcher
y of Bath A world- vertically
Hypera Pharma 4035 RequestedMIC
- Exhibitor hospital
Biotech Hypera researcher Hypera
CAMPUS y
research sis one of sclass
are are
Ferrer Internacional,
6046 S.A.
Requested or
Biotech Privately- Pharma
Pharma is Ferrer has
pharma, partnering
aheld
leading was partnering
Nippon Kayaku Co.,
4035Ltd.
Requested or
Biotech Nippon Nippon a proven
therapeuti
pharma, company
multinatio founded
track
STADA 1511 Requested or
Biotech Kayaku Kayaku
STADA
therapeuti
pharma, nal
Co., Ltd. record
Co., Ltd. in
Aché - Exhibitor 4421 Requested or
Biotech Aché is a is a
therapeuti is a
pharma, is a
German
ALVOGEN 1421 Declined or
Biotech leading
Alvogen Alvogen
therapeuti
pharma, Brazilian pharmace
Zeria Pharmaceutical
4217 Requested
Co, Ltd or
Biotech is an
Zeria is the next
Zeria
therapeuti
pharma, pharmace
internatio generatio
Apotex Corporation
1412 Declined or
Biotech Apotex Pharmace
Pharmace Apotex
therapeuti
pharma, nal
utical is a n
utical
4725 RequestedSPONSO Biotech Novartis has
Novartis - Exhibitor or Inc. is a NOVARTanis a
therapeuti Canadian-
pharma, Tokyo- integrated Tokyo-
Zambon Group SPA 4217 RequestedR PRESEN or Biotech contract
Zambon IS Zambon
therapeuti
pharma, based
manufact portfolio
TING or Biotech, contract Biotech is
COMPA therapeuti
pharma, uringthe Centre manufact
part of the
NY therapeuti of Zambon
Accord Healthcare
4344 Requested Biotech With an With a
Teuto Laboratories
1711 Requested or
Biotech extensive Renowne
Laborator robust
Cristália pharma,
or presence
io Teuto productd for
4035 Requested Biotech CRISTÁL CRISTÁL
therapeuti
pharma, in North portfolio
Brasileiro pioneerin
Fiocruz - Fundação
4035Oswaldo Cruz or
Institute, Fiocruz is IA
IA is a is a
Fiocruz
therapeuti private
pharma, is one of private
g the
Tokyo Medical And
1417Dental University hospital
Academic oneThe of the runs Tokyo more
therapeuti
research owned
most owned
than a
GlobalData - Exhibitor
4406 , tech
IT, Tokyo
GlobalDa Medical
GlobalDa
transfer respected
informati Medical thousand
andserves
Menarini Group 3623 Requested Biotech Multinati ta
ta is a MENARI
on and
data and Dental overis a
Ajinomoto Co., Inc.
4619 Requested or
Biotech The onal NI
The
pharma, analytics fully
pharma 4,000
Chiesi Farmaceutici
4807SpA
RequestedBIO or Ajinomot
Biotech Chiesi Ajinomot
The
therapeuti
pharma, company
o integrated
EMS 2525 BOARD or
Biotech Farmaceu o
Group
EMS/NC
Group
Chiesi
EMS/NC
animal is
pharma, Pharma a global
tici is a Group is a global
Teijin Limited 1421 Requested or
Biotech Teijin is Pharma Teijin isisa
therapeuti
pharma, Global
the #1 currently
the #1
University of Dundee
5707 or
Biotech contribute
The technolog
In the
therapeuti to
pharma, pharma
value pharma
y-driven
Apsen Pharmaceuticals
1412 Requested or
Biotech APSEN is School
Universit APSENof
therapeuti
pharma, maximiza
y of global
Life
Instituto Butantan
4035 or
Biotech a
Instituto has been
Instituto
therapeuti Dundee
Brazilian Sciences,
pharma, Butantan, is in the
Glenmark Pharmaceuticals
4035 MEMBE or
Biotech Glenmark Butantan Below
therapeuti pharmace
founded local
pharma, Pharmace is a
Hisamitsu Pharmaceutical
4807 Requested R
Co., Inc. or
Biotech Hisamitsu descriptioGlobal
therapeuti uticals
pharma, in 1901isto n century-
is given
BIOCODEX Inc. 5923 Declined or
Biotech Biocodex HQ
Pharmace is in
Biocodex
therapeuti
pharma, a global,
utical in two
Saga,
Nissan Chemical4035
Corporation or
Biotech is a
Nissan is a Us
About
therapeuti
pharma, Co.,family- Inc. Japan,
family-
Almirall S.A 4815 Declined or Chemical
Biotech Almirall Almirall Nissan
therapeuti
pharma, is owned
is aan owned
Chemical
LIBBS 4035 or
Biotech Libbs is a is a is
Libbs
therapeuti leading
pharma, oligonucl leading
Corporati
National Research Council Canada
3019 or
Biotech top 10
Canada's seeking
The
therapeuti Medical on was
global
CMIC Group pharma,
or Brazilian
premier new National
2223 Biotech CMIC CMIC
therapeuti
pharma, pharmace
research opportuni
Research
Innovent Biologics,
1421Inc.
Declined or
Biotech Innovent GROUP
offers Inspired
therapeuti organizati
end-to- Council
pharma, Biologics is athe
Apeloa Pharmaceutical
2119 Co. or
CMO, Apeloa is by Apeloa
therapeuti is
pharma, end a leading
spirit of
Teijin Pharma LimitedRequested
1421 CRO a
Biotech Teijin leading CDMO
Teijin is
therapeuti leading
CDMO "Start
Olon SpA 6151 or
CMO, Pharma is the
Olon Pharma
Olon canis
Sumitomo Pharma Co.,Ltd
Requested pharma, from
CRO a
Group is
contract
a fully
offer
4245 Biotech Sumitom Sumitom
therapeuti subsidiary
a global integrated
complete
AGC Inc. 5235 or
CMO, o
AGCPharmaInc. o 1) AGC is
pharma, leader
Co., in Pharma's
Ltd., integrated
CMIC Holdings Co.,
2223Ltd. CRO
Biotech CMICis a rapidly
CMIC
therapeuti is a R&D
multinatio goal
growingis to
DKSH 3424 Requested or
Biotech offers
DKSH GROUPis
DKSH
pharma, nal
or end-to- pharmaceis leading
a
Chugai Pharmaceutical
3027 Co., Ltd PRESEN Biotech Healthcar
Chugai, a aChugai, a
therapeuti end
pharma, member
e, a leading
healthcare
Greater Paris University TING
4635 Hospitals/APHP or
Academic Technolo The member
COMPA therapeuti of
pharma, leading
Roche of company
Roche
Biolab Farmacêutica
4035 Requested ,Biotech
tech gy
Biolab is OfficeBiolab of is
NY therapeuti
transfer group,
Transfer is group, is
Kowa Company,5407Ltd. RequestedMEMBE or
Biotech a major Technolo
Global one of the
Kowa
pharma, Office
pharmaof gy largest
2111 RequestedR
Orion Corporation or
Biotech fully-
Orion Company,
Orion
animal and
integrated Brazilian
pharma, Corporati Ltd.
Kyowa Kirin 6035 or
Biotech Kyowa Corporati Kyowa
therapeuti on
pharma, pharmace
is a (Kowa)
on is a is
Aristo Pharma GmbHDeclined
2111 or
Biotech Aristo is Kirin
Kirin is Aristo
therapeuti
pharma, European,
Japan European,
Group
STALLERGENES GREER
1511 Requested or
Biotech a
Stallergen Pharma
We are is
therapeuti
pharma, es based
pharmace companie
a family
THEA OPEN INNOVATION
1011 or
Biotech Thea Greer committe
Thea is a
therapeuti
pharma, utical
is a fully ownedd to
Alfresa Holdings4235
Corportion
Declined or
Biotech Alfresa is pharma
Open The
therapeuti Innovatio
pharma, integrated company
furthering
Clarivate 4040 or
Biotech Clarivate Alfresa
a Japan- At
therapeuti
pharma, n is
based part specialize
Servier 5607 Declined SPONSO or
Biotech ™ is a is Group
Servier Clarivate,
A
is
partner
therapeuti healthcare
pharma, aglobal engaged
we
Pharmascience 1421 R or €5.3bn with
Biotech Pharmasc Pendopha
animal leader
pharma, ience
independe in empower
strong
Japan Blood Products
4421 Organization or
Biotech We are rm, Inc. <Out- a
therapeuti is
pharma, nt a full- division
commitm
GSK 4023 RequestedBIO or
Biotech theGSK No.1
is a licensing
We are a
therapeuti
pharma, service
plasma of
opportuni
BOARD or fully global
therapeuti
pharma, focused ties>
fractionati biopharm
therapeuti biopharm a
Senju Pharmaceuticals
4821 Co. Ltd Biotech Senju is a Research-
Taiho Pharmaceutical
1917 Requested
Co., Ltd. or
Biotech research- Taiho
Taiho based
pharma,
or based Japanese
Italfarmaco Group4344 Biotech -Pharmace
In- Pharmace
NO
therapeuti
pharma, Japanese
utical, a pharmace
utical, a
UKRI - STFC 2025 or
Other licensing
STFC is a SERVICE
STFC is a
therapeuti of
pharma, subsidiary
late subsidiary
PROVID
National Institute for
1817 Health Research R&D
Institute, National world-
(NIHR) United The
therapeuti
services stage ERS
Maruho Co., Ltd.1011 Requested hospital Kingdom
Biotech Institute leading
Maruho NIHR
Maruho
research governme
for Health research
helpsLtd.
Recordati 5151 or
Biotech No Co., Ltd. Co.,
Recordati,
pharma, and
is a Care industry
is a
Otsuka Pharmaceutical
4049 Declined
Factory or
Biotech We are establishe
service (Out-
therapeuti providers
pharma, leading d leading
in 1926,
Fuso Pharmaceutical
3416 Industries, Ltd. or
Biotech Fuso one of the license:
Fuso
therapeuti
pharma, meeting
main is a listed
Grifols Engineering
4149SA - Exhibitor or
Biotech Pharmace NO-
Grifols Pharmace
EXPERIE
therapeuti
pharma, operating
utical 13065)
utical
KISSEI Pharmaceutical
2111 Declined
Co., Ltd. or
Biotech Engineeri
Kissei is a NCE
Kissei is a
therapeuti
pharma, Industries
ng Industries
YOU
Bayshore Specialty
4315Rx or
Biotech Bayshore R&D
R&D Bayshore
therapeuti oriented
pharma, specialize oriented
CAN
Eisai Co., Ltd. 1811 RequestedMEMBE or Biotech Eisai Co, Specialty
is a Eisai Co.,
therapeuti
pharma, Japanese
leading Japanese
Rx
Sanofi's Vaccines4035
Business R
SPONSO or
Biotech Ltd
Sanofi's Ltd.Ltd is
Sanofi’s
therapeuti
pharma, vaccines one
Canadian of the
Laboratorio Reig5219
Jofre, S.A. R or
Biotech RJ has a vaccines Reig Jofre
therapeuti
pharma, strong
business is business
Faes Farma S. A.1917 Declined or
Biotech Faes 2021a
therapeuti portfolio
pharma, is the is seeking
Spanish
Esteve 6139 Requested or
Biotech FarmaESTEVE Turnover
Since it
therapeuti
pharma, in
S.A pharmace
was
KM Biologics Co.,2111
Ltd.Requested or
Biotech is a
KM was 399
>KM
therapeuti 1933,
leading mio
pharma, Biologics founded€.
UBE Corporation 917 Declined or
Biotech UBE Biologics
UBE
therapeuti
pharma, private
is a in 1929,
Grünenthal GmbH 4914 Declined or
Biotech corporatio
The corporatio
The
therapeuti n
pharma, Japanese
is a n is one
Grifols 4149 Requested or
Biotech Grifols is Grünenth
Grünenth Grifols is
therapeuti
pharma, drug
al Group of al the
Group
Ceva Animal Health
4235 Declined or
Biotech a
Ceva a leading
“Together
therapeuti
pharma, is an
healthcare – an
global
Ipsen 1917 Declined or
Biotech SantéIpsen is a ,Ipsen
our
therapeuti
pharma, company
Animale healthcare
passionat
Intas Pharmaceuticals
5219 Scheduled or
Biotech global
Intas is a sells
Intas over
is a
animal
pharma, is a fast 20
biopharm e people
drugs
Ferring Pharmaceuticals
6046 Requested or multinatio
Biotech Ferring is Headquarvertically
therapeuti
pharma, aceutical
nal in more
integrated
Cancer Research4235
Horizons or
MEMBE Academic a
Cancer tered in
Cancer
animal pharmace
research- global
Santen Pharmaceutical Co., Ltd. R
4035 Declined ,pharma,
tech
Biotech Research St. Prex,
Santen is Research
Santen is
therapeuti
transfer driven,
Horizons Switzerla
Toray Industries1417 Requested or a
Biotech - Torayglobal aUKglobal
Toray
pharma, (CRH) is pharmace
pharmace (CRUK)
Apobiologix 1412 industrial
Biotech Group
Apobiolo is Group
For
therapeuti
& utical
an utical
fuses
VIRBAC SA 4807 or
Biotech gix is
Worlwide a Canada,
Founded
environm Advanced
division nanotechn
pharma, pharmace LATAM
or in 1968
therapeuti of
pharma, utical Apotex and
by athe
animal laboratory French
Number ofFounded OwnershipLicensing oCompany oTicker Market ca Last fundi Total fundWebsite
1,000 to Public Seeking We are BHC www.bauschhealth.com
10,000than 1885
More Private in- primarily
We https://www.boehringer-ingelh
10,000 licensing embrace
interested
2016 Private We would 100 www.illuminaVentures.com
opportuni the
in in-
power
More than 1863 Public Seeking be BAYN www.bayer.com
of
interested
10,000to 1972
1,000 Private in-
Seeking Cristalia http://www.cristalia.com.br/
licensing in
10,000
More than 1896 Private in- is https://www.gene.com/
opportuni
licensing searching
10,000
More than 2023 Public Seeking Partnerin RVTY 12780 www.revvity.com
opportuni for
10,000
1,000 to 1917 Public out-
Seeking gOrionand out-
is http://orion.fi/en/
10,000than 1956 licensing
in- licensing
looking NYSE:
More Public Seeking Discuss https://www.thermofisher.com
opportuni
licensing discussio
for in-
10,000 in- technolog TMO
opportuni licensing,
licensing y and
opportuni commerci
Main emaiMain phonCountry State City Street addPostal code
andrea.fle United New Bridgewa
minggowi States
Germany Jersey ter
ng@baus
info@illu United CA San 200 94404
chhealth.c
minaVent States
United Francisco, Lincoln
ures.com States CA Centre
julio.cord +55 11 Brazil São Paulo Campinas
Drive,
eiro@cris 98799- United CA ,South
SP San
talia.com. 3286 States Francisco
ir@revvit United MA Waltham 940 2451
br
y.com States
Finland Espoo Winter
P.O. Box 2101
Street
65
1(800) United CA
955-6288 States